No definition available.
Other congenital malformations of intestine, including avohilmo
Q17_OTHER_CONGEN_MALFO_INTESTINE_WIDE
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
426 |
4. Check minimum number of eventsNone |
426 |
5. Include endpointsNone |
426 |
6. Filter based on genotype QC (FinnGen only) |
408 |
Control definitions (FinnGen only)
- Control exclude
- Q17_OTHER_CONGEN_MALFO_DIGES_SYSTEM1
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF13
- Parent code in ICD-10
- Q3[8-9]|Q4[0-5]
- Name in latin
- Aliae malformationes congenitae intestini
Similar endpoints
↥List of similar endpoints to
Other congenital malformations of intestine, including avohilmo
based on the number of shared cases.
Similar with more cases:
- Other congenital malformations of the digestive system, including avohilmo
- Congenital malformations, deformations and chromosomal abnormalities, including avohilmo
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 408 | 234 | 174 |
| Unadjusted period prevalence (%) | 0.08 | 0.08 | 0.08 |
| Median age at first event (years) | 52.62 | 52.71 | 52.50 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 426
- Matched controls
- 4260
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q43.0
ICD-10 Finland
Meckel diverticulum
+∞
229.6
199
*
Q43.8
ICD-10 Finland
Other specified congenital malformations of intestine
+∞
128.9
117
*
JFB00
NOMESCO Finland
Partial resection of small intestine
26.8
73.7
52
22
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
5.4
59.5
160
424
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
4.6
53.3
266
1124
JFA73
NOMESCO Finland
Excision of lesion of small intestine
+∞
46.7
44
*
P01AB01
ATC
metronidazole; oral, rectal
4.1
45.7
254
1124
Q43.1
ICD-10 Finland
Hirschsprung disease
+∞
45.6
43
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
8.9
43.6
58
74
K57.9
ICD-10 Finland
Diverticular disease of intestine, part unspecified, without perforation or abscess
12.2
42.2
44
40
K57.2
ICD-10 Finland
Diverticular disease of large intestine with perforation and abscess
14.4
39.6
37
28
JEA00
NOMESCO Finland
Appendectomy
6.7
38.7
67
115
UJF32
NOMESCO Finland
Coloscopy
3.8
37.7
174
661
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.2
37.0
87
199
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
9.4
30.6
38
44
WX302
NOMESCO Finland
Thoracal epidural anesthesy
6.4
25.8
45
77
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
3.1
24.8
146
619
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
23.0
23.8
34
16
JAH00
NOMESCO Finland
Laparotomy
7.1
23.8
37
56
Q43.5
ICD-10 Finland
Ectopic anus
+∞
23.1
22
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.9
23.1
165
773
Q43.30
ICD-10 Finland
Template rotation of colon
+∞
22.1
21
*
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
9.5
21.4
26
29
A06AC01
ATC
ispaghula (psylla seeds); oral
2.8
21.2
150
694
JN3AD
NOMESCO Finland
Abdominal CT examination
3.5
21.1
86
290
ZXD05
NOMESCO Finland
Urgent procedure
2.7
20.9
166
814
K57.1
ICD-10 Finland
Diverticular disease of small intestine without perforation or abscess
17.8
19.5
30
18
ZXE10
NOMESCO Finland
More than one and less than three hours
2.5
18.7
189
1028
JAH01
NOMESCO Finland
Laparoscopy
5.2
18.6
40
83
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
18.4
153
758
J01MA02
ATC
ciprofloxacin; systemic
2.4
17.7
189
1048
D06
ICPC
Abdominal pain localized other
3.5
17.6
68
220
D01
ICPC
Abdominal pain/cramps general
2.9
16.9
94
378
TJF80
NOMESCO Finland
Ostomy education
17.2
16.8
26
16
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
16.6
91
362
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.6
15.9
116
535
N02AX02
ATC
tramadol; systemic, rectal
2.3
15.5
200
1188
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.5
15.3
123
593
R10.0
ICD-10 Finland
Acute abdomen
6.1
14.2
25
43
TPH07
NOMESCO Finland
Cathetrisation of artery
2.9
13.7
70
267
Q43.9
ICD-10 Finland
Congenital malformation of intestine, unspecified
+∞
13.6
13
*
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
3.5
13.2
48
149
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
12.8
182
1102
K57
ICD-10 Finland
Diverticular disease of intestine
9.0
11.7
24
28
TJD20
NOMESCO Finland
Change of gastrostomy tube
23.7
11.6
16
7
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
11.5
112
579
Q43.2
ICD-10 Finland
Other congenital functional disorders of colon
+∞
11.5
11
*
Q42.2
ICD-10 Finland
Congenital absence, atresia and stenosis of anus with fistula
+∞
11.5
11
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.6
11.3
75
326
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.5
11.3
41
127
Z2221
NOMESCO Finland
Medical doctor
2.1
10.9
136
774
JDB00
NOMESCO Finland
Gastrostomy
61.6
10.7
12
*
K59.0
ICD-10 Finland
Constipation
3.3
10.6
42
137
UJF30
NOMESCO Finland
Ileoscopy through colon
2.8
10.5
57
223
JFA74
NOMESCO Finland
Laparoscopic excision of lesion of small intestine
+∞
10.5
10
*
Q42.0
ICD-10 Finland
Congenital absence, atresia and stenosis of rectum with fistula
+∞
10.5
10
*
K35.9
ICD-10 Finland
Acute appendicitis, unspecified
3.1
10.4
45
155
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
11.0
10.4
19
18
K65.0
ICD-10 Finland
Acute peritonitis
15.1
10.1
16
11
WX882
NOMESCO Finland
High dependency care
3.9
10.1
30
81
JF2AB
NOMESCO Finland
Colongraphy with X-ray
41.1
10.0
12
*
K59.09
ICD-10 Finland
Constipation, unspecified
3.0
9.9
47
171
A03FA02
ATC
cisapride; oral, rectal
3.2
9.7
40
134
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.2
9.7
96
497
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.7
9.7
57
233
A06AD11
ATC
lactulose; oral
2.4
9.5
71
326
K56.2
ICD-10 Finland
Volvulus
12.7
9.4
16
13
Q42.3
ICD-10 Finland
Congenital absence, atresia and stenosis of anus without fistula
+∞
9.4
9
*
7513A
ICD-9 Finland
Other congenital anomalies of digestive system, Hirschsprung's disease and other congenital functional disorders of colon[MORBUS HIRSCHPRUNG]
+∞
9.4
9
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
9.2
82
405
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
8.0
9.2
20
26
RD210, ,
NOMESCO Finland
4.4
9.0
23
55
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
24.6
9.0
12
5
Z3226
NOMESCO Finland
Physiotherapist
2.1
8.9
98
527
UJD02
NOMESCO Finland
Gastroscopy
3.5
8.8
31
94
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
8.7
208
1454
JFB47
NOMESCO Finland
Laparoscopic resection of sigmoid colon
10.3
8.6
16
16
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.5
8.6
57
247
K56.7
ICD-10 Finland
Ileus, unspecified
7.6
8.5
19
26
WX402
NOMESCO Finland
General anaesthesia
2.0
8.5
116
674
JGB20
NOMESCO Finland
Partial rectosigmoidectomy and abdominoperineal pull-through anastomosis
91.8
8.4
9
*
6504
FHL
Reconstruction
+∞
8.4
8
*
K92.1
ICD-10 Finland
Melaena
3.3
8.3
32
103
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.2
8.2
78
395
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.4
8.2
59
266
A02BC01
ATC
omeprazole; systemic
1.9
8.1
119
707
A02BC05
ATC
esomeprazole; systemic
1.8
8.1
169
1125
WX002
NOMESCO Finland
Sedation and analgesia
2.1
8.0
88
472
N30.0
ICD-10 Finland
Acute cystitis
2.1
7.9
82
430
Z3231
NOMESCO Finland
Registered nurse
1.9
7.9
135
845
A02BC02
ATC
pantoprazole; systemic
1.8
7.8
275
2132
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
7.8
103
590
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.4
7.8
28
86
J01MA12
ATC
levofloxacin; systemic
2.1
7.8
81
425
Z2446
NOMESCO Finland
Social worker
2.5
7.8
49
207
N03AX11
ATC
topiramate; oral
4.2
7.6
20
49
J01DB01
ATC
cefalexin; oral
2.1
7.5
352
2969
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.3
7.5
63
303
ZXE00
NOMESCO Finland
One hour or less
1.8
7.5
174
1191
N02BE01
ATC
paracetamol; systemic, rectal
2.2
7.5
371
3195
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
4.0
7.3
21
55
368
Kela drug reimbursment
Combination product containing docusate sodium and sorbitol
+∞
7.3
7
*
Q87.26
ICD-10 Finland
VATER association
+∞
7.3
7
*
A06AG10
ATC
docusate sodium, incl. combinations; rectal
+∞
7.3
7
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.2
7.3
29
95
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
7.3
78
413
UJG02
NOMESCO Finland
Proctoscopy
6.8
7.2
17
26
TQW40
NOMESCO Finland
Remowal of suture of skin
2.8
7.2
37
141
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
6.2
7.2
18
30
M79.6
ICD-10 Finland
Pain in limb
1.7
7.1
194
1387
D92
ICPC
Diverticular disease
8.5
6.9
14
17
UKC02
NOMESCO Finland
Cystoscopy
2.1
6.8
67
343
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.7
6.8
38
151
WX892
NOMESCO Finland
Monitored bed care
2.6
6.7
40
164
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.3
6.6
17
41
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.8
6.6
110
677
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.3
6.5
51
238
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.2
6.5
26
86
JFH10
NOMESCO Finland
Total colectomy and ileostomy
70.9
6.4
7
*
D29
ICPC
Digestive symptom/complaint other
3.9
6.4
19
51
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
14.6
6.4
10
7
K57.0
ICD-10 Finland
Diverticular disease of small intestine with perforation and abscess
14.6
6.4
10
7
JWA00
NOMESCO Finland
Repair of wound dehiscence in gastroenterological surgery
14.6
6.4
10
7
K50.0
ICD-10 Finland
Crohn disease of small intestine
6.7
6.4
15
23
N05CF02
ATC
zolpidem; oral
2.0
6.4
73
396
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
4.0
6.3
18
47
JEW96
NOMESCO Finland
Other operation on appendix
+∞
6.3
6
*
GD1RA
NOMESCO Finland
Dynamic X-ray examination of respiratory organs with convetional X-ray picture
+∞
6.3
6
*
JFF10
NOMESCO Finland
Loop enterostomy
27.1
6.2
8
*
WX110
NOMESCO Finland
Infiltration anesthesia
1.8
6.2
309
2560
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.3
6.1
47
217
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
8.8
6.1
12
14
S18
ICPC
Laceration/cut
1.7
6.0
200
1485
XKD00
NOMESCO Finland
Uroflowmetry
2.1
6.0
59
302
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
metronidazole; oral, rectal
P01AB01 [21604857]
P01AB01 [21604857]
1.7e+00
2.0e+00
3.5e+00
1.0e+50
4.8e+00
2.3e+00
1.6e+00
cases:24.34%
controls:5.65%
cases:11.35%
controls:1.72%
cases:6.07%
controls:0.19%
cases:14.51%
controls:0.00%
cases:13.53%
controls:0.13%
cases:14.09%
controls:1.61%
cases:22.13%
controls:5.28%
92
213
286
3557
43
65
336
3711
23
7
356
3769
55
0
324
3776
51
5
326
3768
52
60
317
3663
77
182
271
3265
Other and unspecified abdominal pain
R10.4 [45568113]
R10.4 [45568113]
1.6e+00
2.0e+00
4.3e+00
1.0e+50
3.1e+00
2.3e+00
1.3e+00
cases:17.20%
controls:3.98%
cases:9.50%
controls:1.40%
cases:8.71%
controls:0.13%
cases:10.03%
controls:0.00%
cases:4.51%
controls:0.21%
cases:13.55%
controls:1.53%
cases:17.82%
controls:5.60%
65
150
313
3620
36
53
343
3723
33
5
346
3771
38
0
341
3776
17
8
360
3765
50
57
319
3666
62
193
286
3254
Upper gastrointestinal surgery
106 [44777669]
106 [44777669]
1.0e+00
1.9e+00
3.2e+00
1.0e+50
4.1e+00
2.6e+00
1.4e+00
cases:18.52%
controls:7.45%
cases:14.51%
controls:2.49%
cases:8.71%
controls:0.37%
cases:24.80%
controls:0.00%
cases:13.00%
controls:0.24%
cases:27.64%
controls:2.66%
cases:25.29%
controls:8.06%
70
281
308
3489
55
94
324
3682
33
14
346
3762
94
0
285
3776
49
9
328
3764
102
99
267
3624
88
278
260
3169
Gastroenterology
10 [38004455]
10 [38004455]
9.6e-01
1.8e+00
2.8e+00
1.0e+50
2.2e+00
1.6e+00
1.1e+00
cases:8.99%
controls:3.66%
cases:7.65%
controls:1.30%
cases:3.43%
controls:0.21%
cases:4.22%
controls:0.00%
cases:2.39%
controls:0.27%
cases:8.94%
controls:1.88%
cases:14.08%
controls:5.28%
34
138
344
3632
29
49
350
3727
13
8
366
3768
16
0
363
3776
9
10
368
3763
33
70
336
3653
49
182
299
3265
Diverticular disease of large intestine without perforation or abscess
K57.3 [45567316]
K57.3 [45567316]
2.4e+00
2.7e+00
1.0e+50
1.0e+50
—
3.0e+00
2.0e+00
cases:16.67%
controls:1.83%
cases:8.18%
controls:0.61%
cases:2.37%
controls:0.00%
cases:7.39%
controls:0.00%
—
—
cases:14.91%
controls:0.83%
cases:17.53%
controls:2.73%
63
69
315
3701
31
23
348
3753
9
0
370
3776
28
0
351
3776
—
55
31
314
3692
61
94
287
3353
cefalexin; oral
J01DB01 [21602870]
J01DB01 [21602870]
6.9e-01
8.7e-01
1.9e+00
—
3.1e+00
1.2e+00
7.7e-01
cases:45.24%
controls:29.36%
cases:19.26%
controls:9.06%
cases:7.12%
controls:1.14%
—
—
cases:17.77%
controls:0.95%
cases:25.20%
controls:9.21%
cases:43.10%
controls:25.88%
171
1107
207
2663
73
342
306
3434
27
43
352
3733
—
67
36
310
3737
93
343
276
3380
150
892
198
2555
Outpatient Visit
OP [9202]
OP [9202]
5.4e-01
4.9e-01
6.7e-01
3.7e+00
9.1e-01
1.0e+00
7.2e-01
cases:75.66%
controls:64.54%
cases:56.99%
controls:44.86%
cases:19.26%
controls:10.83%
cases:17.41%
controls:0.50%
cases:22.55%
controls:10.52%
cases:70.19%
controls:46.12%
cases:86.49%
controls:75.72%
286
2433
92
1337
216
1694
163
2082
73
409
306
3367
66
19
313
3757
85
397
292
3376
259
1717
110
2006
301
2610
47
837
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
N02BE01 [21604344]
4.2e-01
6.0e-01
8.6e-01
2.9e+00
1.8e+00
8.1e-01
6.2e-01
cases:36.51%
controls:27.40%
cases:23.22%
controls:14.27%
cases:6.33%
controls:2.78%
cases:2.37%
controls:0.13%
cases:13.26%
controls:2.39%
cases:28.73%
controls:15.15%
cases:52.59%
controls:37.45%
138
1033
240
2737
88
539
291
3237
24
105
355
3671
9
5
370
3771
50
90
327
3683
106
564
263
3159
183
1291
165
2156
Emergency Room Visit
ER [9203]
ER [9203]
6.9e-01
9.8e-01
2.2e+00
—
2.3e+00
9.3e-01
7.8e-01
cases:47.62%
controls:31.33%
cases:26.12%
controls:11.76%
cases:14.78%
controls:1.80%
—
—
cases:12.47%
controls:1.46%
cases:25.47%
controls:11.87%
cases:49.71%
controls:31.27%
180
1181
198
2589
99
444
280
3332
56
68
323
3708
—
47
55
330
3718
94
442
275
3281
173
1078
175
2369
Extensive abdominal CT
JN3BD [2001305556]
JN3BD [2001305556]
1.4e+00
2.2e+00
—
1.0e+50
1.0e+50
2.9e+00
1.3e+00
cases:3.44%
controls:0.88%
cases:2.90%
controls:0.32%
—
—
cases:4.49%
controls:0.00%
cases:1.59%
controls:0.00%
cases:3.25%
controls:0.19%
cases:3.74%
controls:1.04%
13
33
365
3737
11
12
368
3764
—
17
0
362
3776
6
0
371
3773
12
7
357
3716
13
36
335
3411
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
8.8e-01
1.1e+00
2.5e+00
—
2.2e+00
1.2e+00
3.5e-01
cases:7.67%
controls:3.34%
cases:5.01%
controls:1.77%
cases:2.11%
controls:0.19%
—
—
cases:2.92%
controls:0.34%
cases:6.50%
controls:2.10%
cases:9.48%
controls:6.90%
29
126
349
3644
19
67
360
3709
8
7
371
3769
—
11
13
366
3760
24
78
345
3645
33
238
315
3209
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1798-8 [3016771]
7.5e-01
1.4e+00
2.1e+00
—
2.1e+00
1.5e+00
6.6e-01
cases:6.35%
controls:3.10%
cases:5.28%
controls:1.38%
cases:1.85%
controls:0.24%
—
—
cases:1.86%
controls:0.24%
cases:5.69%
controls:1.37%
cases:12.36%
controls:6.82%
24
117
354
3653
20
52
359
3724
7
9
372
3767
—
7
9
370
3764
21
51
348
3672
43
235
305
3212
Inpatient Hospital
21 [8717]
21 [8717]
6.8e-01
7.4e-01
1.8e+00
—
2.4e+00
1.3e+00
6.4e-01
cases:48.41%
controls:32.12%
cases:20.84%
controls:11.18%
cases:8.97%
controls:1.62%
—
—
cases:13.26%
controls:1.35%
cases:29.81%
controls:10.42%
cases:39.37%
controls:25.47%
183
1211
195
2559
79
422
300
3354
34
61
345
3715
—
50
51
327
3722
110
388
259
3335
137
878
211
2569
General Surgery
2 [38004447]
2 [38004447]
7.5e-01
5.8e-01
2.2e+00
1.0e+50
2.5e+00
1.3e+00
7.6e-01
cases:31.75%
controls:17.96%
cases:9.23%
controls:5.40%
cases:6.60%
controls:0.77%
cases:23.48%
controls:0.00%
cases:5.84%
controls:0.50%
cases:15.18%
controls:4.49%
cases:25.29%
controls:13.72%
120
677
258
3093
35
204
344
3572
25
29
354
3747
89
0
290
3776
22
19
355
3754
56
167
313
3556
88
473
260
2974
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
1.6e-01
3.3e-01
1.4e+00
4.3e+00
1.8e+00
3.7e-01
1.6e-01
cases:20.37%
controls:17.96%
cases:20.84%
controls:15.89%
cases:12.40%
controls:3.42%
cases:10.55%
controls:0.16%
cases:16.18%
controls:3.18%
cases:24.39%
controls:18.24%
cases:47.41%
controls:43.34%
77
677
301
3093
79
600
300
3176
47
129
332
3647
40
6
339
3770
61
120
316
3653
90
679
279
3044
165
1494
183
1953
ispaghula (psylla seeds); oral
A06AC01 [21600555]
A06AC01 [21600555]
1.0e+00
1.4e+00
2.1e+00
—
—
1.6e+00
1.3e+00
cases:7.41%
controls:2.76%
cases:5.80%
controls:1.56%
cases:2.37%
controls:0.29%
—
—
—
—
cases:8.67%
controls:1.85%
cases:13.51%
controls:4.12%
28
104
350
3666
22
59
357
3717
9
11
370
3765
—
—
32
69
337
3654
47
142
301
3305
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
3.9e-01
4.7e-01
3.0e+00
1.0e+50
2.7e+00
9.5e-01
7.3e-01
cases:6.61%
controls:4.59%
cases:3.43%
controls:2.17%
cases:4.49%
controls:0.24%
cases:2.90%
controls:0.00%
cases:3.98%
controls:0.27%
cases:5.42%
controls:2.18%
cases:15.23%
controls:7.95%
25
173
353
3597
13
82
366
3694
17
9
362
3767
11
0
368
3776
15
10
362
3763
20
81
349
3642
53
274
295
3173
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
1.5e-01
3.8e-01
1.4e+00
4.0e+00
2.0e+00
3.3e-01
1.9e-01
cases:18.78%
controls:16.63%
cases:18.73%
controls:13.59%
cases:10.03%
controls:2.81%
cases:10.03%
controls:0.21%
cases:15.38%
controls:2.49%
cases:21.14%
controls:16.20%
cases:44.83%
controls:40.09%
71
627
307
3143
71
513
308
3263
38
106
341
3670
38
8
341
3768
58
94
319
3679
78
603
291
3120
156
1382
192
2065
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
1.4e-01
3.9e-01
1.4e+00
4.0e+00
1.9e+00
3.3e-01
2.2e-01
cases:18.52%
controls:16.53%
cases:18.47%
controls:13.35%
cases:9.76%
controls:2.73%
cases:10.29%
controls:0.21%
cases:14.85%
controls:2.46%
cases:21.14%
controls:16.12%
cases:45.11%
controls:39.72%
70
623
308
3147
70
504
309
3272
37
103
342
3673
39
8
340
3768
56
93
321
3680
78
600
291
3123
157
1369
191
2078
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
2.1e-01
3.4e-01
1.3e+00
4.2e+00
1.6e+00
3.9e-01
1.5e-01
cases:23.28%
controls:19.79%
cases:22.96%
controls:17.56%
cases:13.98%
controls:4.10%
cases:11.35%
controls:0.19%
cases:18.04%
controls:4.13%
cases:28.18%
controls:20.95%
cases:51.15%
controls:47.43%
88
746
290
3024
87
663
292
3113
53
155
326
3621
43
7
336
3769
68
156
309
3617
104
780
265
2943
178
1635
170
1812
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
2.0e-01
3.1e-01
1.3e+00
4.2e+00
1.6e+00
3.9e-01
1.6e-01
cases:23.02%
controls:19.73%
cases:22.43%
controls:17.48%
cases:13.98%
controls:4.08%
cases:11.35%
controls:0.19%
cases:17.77%
controls:4.13%
cases:28.18%
controls:20.92%
cases:51.15%
controls:47.11%
87
744
291
3026
85
660
294
3116
53
154
326
3622
43
7
336
3769
67
156
310
3617
104
779
265
2944
178
1624
170
1823
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
1.9e-01
3.2e-01
1.3e+00
4.2e+00
1.6e+00
4.0e-01
1.6e-01
cases:23.02%
controls:19.76%
cases:22.69%
controls:17.56%
cases:13.98%
controls:4.08%
cases:11.35%
controls:0.19%
cases:17.77%
controls:4.13%
cases:28.18%
controls:20.90%
cases:51.15%
controls:47.23%
87
745
291
3025
86
663
293
3113
53
154
326
3622
43
7
336
3769
67
156
310
3617
104
778
265
2945
178
1628
170
1819
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
2.0e-01
3.2e-01
1.3e+00
4.2e+00
1.6e+00
3.8e-01
1.5e-01
cases:23.02%
controls:19.68%
cases:22.69%
controls:17.53%
cases:13.98%
controls:4.10%
cases:11.35%
controls:0.19%
cases:17.77%
controls:4.13%
cases:27.91%
controls:20.90%
cases:51.15%
controls:47.29%
87
742
291
3028
86
662
293
3114
53
155
326
3621
43
7
336
3769
67
156
310
3617
103
778
266
2945
178
1630
170
1817
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
2.0e-01
3.2e-01
1.3e+00
4.2e+00
1.6e+00
3.8e-01
1.5e-01
cases:23.02%
controls:19.73%
cases:22.69%
controls:17.56%
cases:13.98%
controls:4.10%
cases:11.35%
controls:0.19%
cases:17.77%
controls:4.13%
cases:27.91%
controls:20.95%
cases:51.15%
controls:47.29%
87
744
291
3026
86
663
293
3113
53
155
326
3621
43
7
336
3769
67
156
310
3617
103
780
266
2943
178
1630
170
1817
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
2.0e-01
3.2e-01
1.3e+00
4.2e+00
1.6e+00
3.9e-01
1.5e-01
cases:23.02%
controls:19.71%
cases:22.69%
controls:17.51%
cases:13.98%
controls:4.10%
cases:11.35%
controls:0.19%
cases:17.77%
controls:4.16%
cases:28.18%
controls:20.95%
cases:51.15%
controls:47.29%
87
743
291
3027
86
661
293
3115
53
155
326
3621
43
7
336
3769
67
157
310
3616
104
780
265
2943
178
1630
170
1817
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
1.9e-01
3.2e-01
1.3e+00
4.2e+00
1.6e+00
3.9e-01
1.5e-01
cases:23.02%
controls:19.81%
cases:22.69%
controls:17.58%
cases:13.98%
controls:4.13%
cases:11.35%
controls:0.19%
cases:17.77%
controls:4.13%
cases:28.18%
controls:20.95%
cases:51.15%
controls:47.32%
87
747
291
3023
86
664
293
3112
53
156
326
3620
43
7
336
3769
67
156
310
3617
104
780
265
2943
178
1631
170
1816
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
7.7e-02
2.4e-01
1.4e+00
4.1e+00
1.6e+00
3.5e-01
2.0e-01
cases:13.76%
controls:12.86%
cases:13.46%
controls:10.94%
cases:9.76%
controls:2.67%
cases:7.65%
controls:0.13%
cases:12.20%
controls:2.81%
cases:17.89%
controls:13.35%
cases:33.33%
controls:29.07%
52
485
326
3285
51
413
328
3363
37
101
342
3675
29
5
350
3771
46
106
331
3667
66
497
303
3226
116
1002
232
2445
Emergency Medicine
93 [38004510]
93 [38004510]
6.7e-01
7.8e-01
2.1e+00
1.0e+50
2.1e+00
8.7e-01
4.7e-01
cases:13.23%
controls:7.21%
cases:9.76%
controls:4.74%
cases:5.54%
controls:0.74%
cases:8.44%
controls:0.00%
cases:5.84%
controls:0.74%
cases:11.38%
controls:5.13%
cases:24.71%
controls:16.97%
50
272
328
3498
37
179
342
3597
21
28
358
3748
32
0
347
3776
22
28
355
3745
42
191
327
3532
86
585
262
2862
Ileoscopy through colon
UJF30 [2001305028]
UJF30 [2001305028]
8.6e-01
2.5e+00
—
—
—
2.5e+00
1.8e+00
cases:1.85%
controls:0.80%
cases:2.11%
controls:0.19%
—
—
—
—
—
—
cases:2.98%
controls:0.24%
cases:4.89%
controls:0.84%
7
30
371
3740
8
7
371
3769
—
—
—
11
9
358
3714
17
29
331
3418
Coloscopy
UJF32 [2001305029]
UJF32 [2001305029]
1.2e+00
2.1e+00
—
1.0e+50
—
2.4e+00
1.1e+00
cases:8.47%
controls:2.76%
cases:5.01%
controls:0.66%
—
—
cases:1.85%
controls:0.00%
—
—
cases:9.49%
controls:0.97%
cases:9.77%
controls:3.48%
32
104
346
3666
19
25
360
3751
—
7
0
372
3776
—
35
36
334
3687
34
120
314
3327
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
4.1e-02
9.5e-02
1.3e+00
3.9e+00
1.5e+00
1.2e-01
-5.0e-02
cases:15.87%
controls:15.33%
cases:13.72%
controls:12.63%
cases:8.97%
controls:2.67%
cases:7.39%
controls:0.16%
cases:11.67%
controls:2.89%
cases:17.07%
controls:15.47%
cases:35.63%
controls:36.79%
60
578
318
3192
52
477
327
3299
34
101
345
3675
28
6
351
3770
44
109
333
3664
63
576
306
3147
124
1268
224
2179
Pain localized to other parts of lower abdomen
R10.3 [45534426]
R10.3 [45534426]
1.6e+00
2.0e+00
—
1.0e+50
—
1.8e+00
1.2e+00
cases:7.41%
controls:1.54%
cases:3.17%
controls:0.45%
—
—
cases:3.69%
controls:0.00%
—
—
cases:4.34%
controls:0.75%
cases:9.20%
controls:2.90%
28
58
350
3712
12
17
367
3759
—
14
0
365
3776
—
16
28
353
3695
32
100
316
3347
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
8.8e-01
8.9e-01
2.2e+00
—
2.2e+00
1.2e+00
3.5e-01
cases:7.14%
controls:3.10%
cases:3.96%
controls:1.67%
cases:1.58%
controls:0.19%
—
—
cases:2.65%
controls:0.29%
cases:5.96%
controls:1.85%
cases:8.33%
controls:6.01%
27
117
351
3653
15
63
364
3713
6
7
373
3769
—
10
11
367
3762
22
69
347
3654
29
207
319
3240
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
2.4e-01
4.4e-01
8.3e-01
4.2e+00
8.3e-01
3.4e-01
1.6e-01
cases:57.41%
controls:51.56%
cases:57.78%
controls:46.80%
cases:33.25%
controls:17.90%
cases:35.88%
controls:0.85%
cases:33.42%
controls:18.02%
cases:59.35%
controls:50.87%
cases:75.57%
controls:72.58%
217
1944
161
1826
219
1767
160
2009
126
676
253
3100
136
32
243
3744
126
680
251
3093
219
1894
150
1829
263
2502
85
945
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
7.8e-01
9.4e-01
2.0e+00
—
2.3e+00
1.2e+00
3.0e-01
cases:7.94%
controls:3.79%
cases:4.22%
controls:1.69%
cases:1.85%
controls:0.26%
—
—
cases:2.92%
controls:0.29%
cases:6.50%
controls:2.07%
cases:9.77%
controls:7.43%
30
143
348
3627
16
64
363
3712
7
10
372
3766
—
11
11
366
3762
24
77
345
3646
34
256
314
3191
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
J01MA02 [21603009]
8.0e-01
1.5e+00
—
1.0e+50
2.7e+00
7.7e-01
1.0e+00
cases:10.85%
controls:5.20%
cases:6.07%
controls:1.48%
—
—
cases:1.32%
controls:0.00%
cases:1.86%
controls:0.13%
cases:3.52%
controls:1.67%
cases:14.66%
controls:5.74%
41
196
337
3574
23
56
356
3720
—
5
0
374
3776
7
5
370
3768
13
62
356
3661
51
198
297
3249
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
2.2e-01
2.7e-01
1.1e+00
3.5e+00
1.2e+00
3.0e-01
1.1e-01
cases:26.46%
controls:22.33%
cases:27.70%
controls:22.70%
cases:19.26%
controls:7.28%
cases:15.04%
controls:0.56%
cases:21.22%
controls:7.26%
cases:32.79%
controls:26.62%
cases:54.89%
controls:52.07%
100
842
278
2928
105
857
274
2919
73
275
306
3501
57
21
322
3755
80
274
297
3499
121
991
248
2732
191
1795
157
1652
Abdominal pain/cramps general
D01 [2002000300]
D01 [2002000300]
1.1e+00
2.0e+00
—
1.0e+50
—
2.0e+00
1.6e+00
cases:2.65%
controls:0.93%
cases:2.37%
controls:0.32%
—
—
cases:2.64%
controls:0.00%
—
—
cases:2.44%
controls:0.35%
cases:6.32%
controls:1.31%
10
35
368
3735
9
12
370
3764
—
10
0
369
3776
—
9
13
360
3710
22
45
326
3402
Outpatient Hospital
22 [8756]
22 [8756]
6.7e-01
6.6e-01
1.2e+00
—
2.3e+00
1.2e+00
7.2e-01
cases:37.83%
controls:23.69%
cases:13.72%
controls:7.63%
cases:2.64%
controls:0.79%
—
—
cases:6.90%
controls:0.74%
cases:20.33%
controls:7.31%
cases:32.76%
controls:19.12%
143
893
235
2877
52
288
327
3488
10
30
369
3746
—
26
28
351
3745
75
272
294
3451
114
659
234
2788
enoxaparin; parenteral
B01AB05 [21600976]
B01AB05 [21600976]
3.9e-01
4.9e-01
-1.0e+50
—
3.0e+00
1.5e+00
8.4e-01
cases:5.82%
controls:4.01%
cases:2.11%
controls:1.30%
cases:0.00%
controls:0.29%
—
—
cases:3.71%
controls:0.19%
cases:5.69%
controls:1.32%
cases:9.20%
controls:4.18%
22
151
356
3619
8
49
371
3727
0
11
379
3765
—
14
7
363
3766
21
49
348
3674
32
144
316
3303
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
9.4e-01
1.0e+00
—
—
2.1e+00
1.3e+00
4.1e-01
cases:6.61%
controls:2.68%
cases:3.96%
controls:1.48%
—
—
—
—
cases:2.12%
controls:0.27%
cases:5.42%
controls:1.50%
cases:7.18%
controls:4.90%
25
101
353
3669
15
56
364
3720
—
—
8
10
369
3763
20
56
349
3667
25
169
323
3278
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
5.6e-01
8.4e-01
1.6e+00
—
1.9e+00
9.6e-01
4.3e-01
cases:8.73%
controls:5.20%
cases:7.65%
controls:3.44%
cases:3.69%
controls:0.74%
—
—
cases:4.51%
controls:0.72%
cases:8.67%
controls:3.52%
cases:16.95%
controls:11.75%
33
196
345
3574
29
130
350
3646
14
28
365
3748
—
17
27
360
3746
32
131
337
3592
59
405
289
3042
General Practice
1 [38004446]
1 [38004446]
6.6e-01
5.0e-01
1.5e+00
—
1.6e+00
9.3e-01
5.4e-01
cases:18.78%
controls:10.72%
cases:7.92%
controls:4.98%
cases:3.96%
controls:0.87%
—
—
cases:3.71%
controls:0.74%
cases:10.84%
controls:4.57%
cases:22.13%
controls:14.24%
71
404
307
3366
30
188
349
3588
15
33
364
3743
—
14
28
363
3745
40
170
329
3553
77
491
271
2956
General anesthesia, balanced
WX408 [2001310808]
WX408 [2001310808]
1.1e+00
1.0e+00
—
1.0e+50
—
2.9e+00
1.3e+00
cases:8.73%
controls:3.16%
cases:2.64%
controls:0.98%
—
—
cases:7.12%
controls:0.00%
—
—
cases:6.50%
controls:0.38%
cases:8.33%
controls:2.47%
33
119
345
3651
10
37
369
3739
—
27
0
352
3776
—
24
14
345
3709
29
85
319
3362
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
2.3e-01
7.9e-01
1.8e+00
—
2.1e+00
3.0e-01
6.1e-01
cases:5.82%
controls:4.69%
cases:6.60%
controls:3.10%
cases:3.17%
controls:0.56%
—
—
cases:4.51%
controls:0.58%
cases:4.61%
controls:3.46%
cases:15.80%
controls:9.28%
22
177
356
3593
25
117
354
3659
12
21
367
3755
—
17
22
360
3751
17
129
352
3594
55
320
293
3127
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
2.7e-01
5.4e-01
1.4e+00
—
2.2e+00
7.1e-01
3.9e-01
cases:19.05%
controls:15.25%
cases:17.41%
controls:10.91%
cases:9.50%
controls:2.44%
—
—
cases:15.65%
controls:2.07%
cases:22.76%
controls:12.70%
cases:43.39%
controls:34.23%
72
575
306
3195
66
412
313
3364
36
92
343
3684
—
59
78
318
3695
84
473
285
3250
151
1180
197
2267
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
1.6e-01
2.8e-01
1.5e+00
—
2.3e+00
9.0e-01
5.5e-01
cases:7.94%
controls:6.87%
cases:4.75%
controls:3.63%
cases:2.90%
controls:0.66%
—
—
cases:3.98%
controls:0.42%
cases:9.21%
controls:3.98%
cases:22.13%
controls:14.04%
30
259
348
3511
18
137
361
3639
11
25
368
3751
—
15
16
362
3757
34
148
335
3575
77
484
271
2963
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
1.8e-01
8.7e-01
2.0e+00
1.0e+50
2.0e+00
1.1e+00
3.9e-01
cases:4.76%
controls:4.01%
cases:5.01%
controls:2.17%
cases:1.58%
controls:0.21%
cases:1.32%
controls:0.00%
cases:2.12%
controls:0.29%
cases:5.15%
controls:1.77%
cases:12.64%
controls:8.96%
18
151
360
3619
19
82
360
3694
6
8
373
3768
5
0
374
3776
8
11
369
3762
19
66
350
3657
44
309
304
3138
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
4.0e-01
6.2e-01
1.5e+00
—
1.6e+00
7.5e-01
4.3e-01
cases:13.76%
controls:9.63%
cases:12.14%
controls:6.89%
cases:5.54%
controls:1.24%
—
—
cases:5.84%
controls:1.19%
cases:14.36%
controls:7.33%
cases:29.60%
controls:21.41%
52
363
326
3407
46
260
333
3516
21
47
358
3729
—
22
45
355
3728
53
273
316
3450
103
738
245
2709
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
5.6e-01
6.6e-01
2.9e+00
1.0e+50
—
1.4e+00
7.5e-01
cases:5.29%
controls:3.10%
cases:2.64%
controls:1.38%
cases:3.17%
controls:0.19%
cases:2.11%
controls:0.00%
—
—
cases:4.34%
controls:1.15%
cases:11.49%
controls:5.77%
20
117
358
3653
10
52
369
3724
12
7
367
3769
8
0
371
3776
—
16
43
353
3680
40
199
308
3248
Pediatric Surgery
OMOP4822020 [45756819]
OMOP4822020 [45756819]
1.2e+00
1.6e+00
—
1.0e+50
—
2.0e+00
1.6e+00
cases:3.44%
controls:1.03%
cases:1.58%
controls:0.32%
—
—
cases:3.17%
controls:0.00%
—
—
cases:4.07%
controls:0.56%
cases:4.89%
controls:0.99%
13
39
365
3731
6
12
373
3764
—
12
0
367
3776
—
15
21
354
3702
17
34
331
3413
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
5.1e-01
7.6e-01
1.7e+00
—
1.7e+00
6.9e-01
2.6e-01
cases:12.96%
controls:8.20%
cases:8.44%
controls:4.13%
cases:3.96%
controls:0.77%
—
—
cases:3.98%
controls:0.72%
cases:10.03%
controls:5.29%
cases:20.98%
controls:16.94%
49
309
329
3461
32
156
347
3620
15
29
364
3747
—
15
27
362
3746
37
197
332
3526
73
584
275
2863
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
6.1e-01
5.0e-01
4.9e-01
2.6e+00
1.0e+00
6.5e-01
8.5e-01
cases:96.03%
controls:92.94%
cases:87.86%
controls:81.38%
cases:53.30%
controls:41.15%
cases:22.43%
controls:2.04%
cases:65.78%
controls:40.90%
cases:89.97%
controls:82.38%
cases:97.41%
controls:94.14%
363
3504
15
266
333
3073
46
703
202
1554
177
2222
85
77
294
3699
248
1543
129
2230
332
3067
37
656
339
3245
9
202
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
6.0e-01
9.7e-02
1.9e+00
—
2.2e+00
7.4e-01
5.4e-01
cases:14.81%
controls:8.67%
cases:3.69%
controls:3.36%
cases:1.85%
controls:0.29%
—
—
cases:2.92%
controls:0.32%
cases:6.78%
controls:3.36%
cases:13.79%
controls:8.56%
56
327
322
3443
14
127
365
3649
7
11
372
3765
—
11
12
366
3761
25
125
344
3598
48
295
300
3152
Abdominal X-ray examination without contrast
JN3AA [2001305553]
JN3AA [2001305553]
2.1e+00
—
—
—
—
2.5e+00
1.3e+00
cases:2.12%
controls:0.27%
—
—
—
—
—
—
—
—
cases:1.90%
controls:0.16%
cases:1.44%
controls:0.38%
8
10
370
3760
—
—
—
—
7
6
362
3717
5
13
343
3434
Bacteria [Presence] in Urine
87829-8 [36304419]
87829-8 [36304419]
9.9e-01
9.3e-01
—
—
2.2e+00
1.3e+00
4.3e-01
cases:6.61%
controls:2.57%
cases:3.43%
controls:1.38%
—
—
—
—
cases:2.12%
controls:0.24%
cases:5.42%
controls:1.53%
cases:7.18%
controls:4.82%
25
97
353
3673
13
52
366
3724
—
—
8
9
369
3764
20
57
349
3666
25
166
323
3281
Other Crohn disease
K50.8 [45533599]
K50.8 [45533599]
—
2.1e+00
—
—
—
2.3e+00
2.2e+00
—
—
cases:1.32%
controls:0.16%
—
—
—
—
—
—
cases:1.36%
controls:0.13%
cases:1.72%
controls:0.20%
—
5
6
374
3770
—
—
—
5
5
364
3718
6
7
342
3440
Infiltration anesthesia
WX110 [2001310767]
WX110 [2001310767]
3.2e-01
6.0e-01
1.6e+00
—
1.5e+00
7.0e-01
5.8e-01
cases:17.46%
controls:13.26%
cases:9.50%
controls:5.43%
cases:2.11%
controls:0.42%
—
—
cases:2.92%
controls:0.64%
cases:11.65%
controls:6.12%
cases:29.31%
controls:18.91%
66
500
312
3270
36
205
343
3571
8
16
371
3760
—
11
24
366
3749
43
228
326
3495
102
652
246
2795
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
8.1e-01
1.1e+00
—
—
—
1.4e+00
1.0e+00
cases:10.32%
controls:4.85%
cases:5.80%
controls:1.93%
—
—
—
—
—
—
cases:7.05%
controls:1.91%
cases:9.20%
controls:3.48%
39
183
339
3587
22
73
357
3703
—
—
—
26
71
343
3652
32
120
316
3327
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
1.5e-01
5.9e-01
1.4e+00
—
1.8e+00
5.8e-01
2.5e-01
cases:18.78%
controls:16.66%
cases:18.47%
controls:11.20%
cases:8.97%
controls:2.49%
—
—
cases:12.20%
controls:2.23%
cases:21.41%
controls:13.27%
cases:43.97%
controls:37.98%
71
628
307
3142
70
423
309
3353
34
94
345
3682
—
46
84
331
3689
79
494
290
3229
153
1309
195
2138
Thoracal epidural anesthesia
WX302 [2001310795]
WX302 [2001310795]
—
—
—
1.0e+50
—
2.3e+00
2.0e+00
—
—
—
—
—
—
cases:2.11%
controls:0.00%
—
—
cases:1.90%
controls:0.19%
cases:2.01%
controls:0.29%
—
—
—
8
0
371
3776
—
7
7
362
3716
7
10
341
3437
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-8.9e-01
-9.7e-01
—
—
—
2.2e+00
3.0e+00
cases:10.85%
controls:22.84%
cases:2.90%
controls:7.31%
—
—
—
—
—
—
cases:4.88%
controls:0.59%
cases:15.52%
controls:0.93%
41
861
337
2909
11
276
368
3500
—
—
—
18
22
351
3701
54
32
294
3415
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
J01CR02 [21602863]
5.2e-01
5.3e-01
-1.0e+50
—
2.3e+00
1.1e+00
7.6e-01
cases:11.38%
controls:7.11%
cases:3.69%
controls:2.20%
cases:0.00%
controls:0.16%
—
—
cases:1.86%
controls:0.19%
cases:6.23%
controls:2.10%
cases:16.09%
controls:8.21%
43
268
335
3502
14
83
365
3693
0
6
379
3770
—
7
7
370
3766
23
78
346
3645
56
283
292
3164
More than three and less than five hours
ZXE20 [2001311408]
ZXE20 [2001311408]
1.2e+00
—
—
—
—
1.8e+00
1.2e+00
cases:3.97%
controls:1.22%
—
—
—
—
—
—
—
—
cases:2.17%
controls:0.38%
cases:3.74%
controls:1.16%
15
46
363
3724
—
—
—
—
8
14
361
3709
13
40
335
3407
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
2.0e-01
4.8e-01
1.4e+00
—
1.9e+00
9.1e-01
5.0e-01
cases:6.35%
controls:5.25%
cases:5.54%
controls:3.50%
cases:3.69%
controls:0.95%
—
—
cases:5.04%
controls:0.82%
cases:7.05%
controls:2.95%
cases:16.38%
controls:10.59%
24
198
354
3572
21
132
358
3644
14
36
365
3740
—
19
31
358
3742
26
110
343
3613
57
365
291
3082
Laceration/cut
S18 [2002000983]
S18 [2002000983]
4.9e-01
3.1e-01
—
—
3.2e+00
8.1e-01
9.7e-01
cases:7.14%
controls:4.51%
cases:2.37%
controls:1.75%
—
—
—
—
cases:4.24%
controls:0.19%
cases:5.42%
controls:2.50%
cases:19.83%
controls:8.59%
27
170
351
3600
9
66
370
3710
—
—
16
7
361
3766
20
93
349
3630
69
296
279
3151
Constipation, unspecified
K59.09 [2000502926]
K59.09 [2000502926]
1.1e+00
—
—
—
—
2.3e+00
1.8e+00
cases:1.59%
controls:0.53%
—
—
—
—
—
—
—
—
cases:1.36%
controls:0.13%
cases:3.16%
controls:0.55%
6
20
372
3750
—
—
—
—
5
5
364
3718
11
19
337
3428
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
2.0e-01
4.6e-01
1.6e+00
—
1.9e+00
5.3e-01
3.9e-01
cases:13.76%
controls:11.56%
cases:15.30%
controls:10.20%
cases:9.23%
controls:2.04%
—
—
cases:10.61%
controls:1.80%
cases:17.34%
controls:10.96%
cases:35.63%
controls:27.21%
52
436
326
3334
58
385
321
3391
35
77
344
3699
—
40
68
337
3705
64
408
305
3315
124
938
224
2509
pantoprazole; oral, parenteral
A02BC02 [21600097]
A02BC02 [21600097]
5.1e-01
7.5e-01
4.7e-01
—
1.3e+00
7.9e-01
6.2e-01
cases:20.63%
controls:13.55%
cases:15.83%
controls:8.18%
cases:2.90%
controls:1.83%
—
—
cases:5.57%
controls:1.59%
cases:17.34%
controls:8.73%
cases:29.31%
controls:18.22%
78
511
300
3259
60
309
319
3467
11
69
368
3707
—
21
60
356
3713
64
325
305
3398
102
628
246
2819
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
UJD10 [2001304788]
1.2e+00
1.6e+00
—
1.0e+50
—
8.7e-01
1.1e+00
cases:10.32%
controls:3.32%
cases:4.22%
controls:0.85%
—
—
cases:1.32%
controls:0.00%
—
—
cases:2.71%
controls:1.15%
cases:10.34%
controls:3.80%
39
125
339
3645
16
32
363
3744
—
5
0
374
3776
—
10
43
359
3680
36
131
312
3316
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
51486-9 [3029879]
8.6e-01
8.0e-01
—
—
2.3e+00
1.6e+00
4.6e-01
cases:2.91%
controls:1.25%
cases:1.58%
controls:0.72%
—
—
—
—
cases:1.59%
controls:0.16%
cases:3.25%
controls:0.67%
cases:4.31%
controls:2.76%
11
47
367
3723
6
27
373
3749
—
—
6
6
371
3767
12
25
357
3698
15
95
333
3352
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
8.9e-01
7.4e-01
—
—
—
1.6e+00
1.2e+00
cases:12.17%
controls:5.36%
cases:3.69%
controls:1.80%
—
—
—
—
—
—
cases:7.59%
controls:1.61%
cases:14.08%
controls:4.50%
46
202
332
3568
14
68
365
3708
—
—
—
28
60
341
3663
49
155
299
3292
More than one and less than three hours
ZXE10 [2001311401]
ZXE10 [2001311401]
9.9e-01
8.1e-01
—
—
—
1.5e+00
1.2e+00
cases:10.85%
controls:4.32%
cases:3.17%
controls:1.43%
—
—
—
—
—
—
cases:7.05%
controls:1.58%
cases:12.64%
controls:4.15%
41
163
337
3607
12
54
367
3722
—
—
—
26
59
343
3664
44
143
304
3304
Abdominal pain localized other
D06 [2002000305]
D06 [2002000305]
2.0e+00
1.6e+00
—
1.0e+50
—
—
1.7e+00
cases:3.70%
controls:0.50%
cases:1.32%
controls:0.26%
—
—
cases:1.85%
controls:0.00%
—
—
—
—
cases:4.89%
controls:0.93%
14
19
364
3751
5
10
374
3766
—
7
0
372
3776
—
—
17
32
331
3415
Internal Medicine
11 [38004456]
11 [38004456]
5.0e-01
7.4e-01
1.2e+00
1.0e+50
8.2e-01
5.6e-01
5.8e-01
cases:29.37%
controls:20.21%
cases:16.09%
controls:8.37%
cases:4.75%
controls:1.48%
cases:3.43%
controls:0.00%
cases:3.18%
controls:1.43%
cases:14.09%
controls:8.54%
cases:29.89%
controls:19.23%
111
762
267
3008
61
316
318
3460
18
56
361
3720
13
0
366
3776
12
54
365
3719
52
318
317
3405
104
663
244
2784
budesonide; oral, sublingual
A07EA06 [21600658]
A07EA06 [21600658]
1.8e+00
—
—
—
—
—
1.8e+00
cases:1.85%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
cases:2.30%
controls:0.41%
7
12
371
3758
—
—
—
—
—
8
14
340
3433
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
6.0e-01
2.4e-01
—
1.0e+50
2.4e+00
1.0e+00
6.6e-01
cases:5.29%
controls:2.97%
cases:1.85%
controls:1.46%
—
—
cases:1.32%
controls:0.00%
cases:2.39%
controls:0.21%
cases:4.34%
controls:1.58%
cases:8.62%
controls:4.64%
20
112
358
3658
7
55
372
3721
—
5
0
374
3776
9
8
368
3765
16
59
353
3664
30
160
318
3287
esomeprazole; oral, parenteral
A02BC05 [21600100]
A02BC05 [21600100]
7.7e-01
1.1e+00
1.2e+00
—
—
7.7e-01
8.3e-01
cases:15.34%
controls:7.75%
cases:9.76%
controls:3.55%
cases:2.90%
controls:0.93%
—
—
—
—
cases:6.78%
controls:3.25%
cases:15.23%
controls:7.28%
58
292
320
3478
37
134
342
3642
11
35
368
3741
—
—
25
121
344
3602
53
251
295
3196
Colonoscopy Study observation
28023-0 [3022145]
28023-0 [3022145]
1.2e+00
2.2e+00
—
—
—
1.4e+00
1.3e+00
cases:2.65%
controls:0.82%
cases:1.85%
controls:0.21%
—
—
—
—
—
—
cases:1.63%
controls:0.40%
cases:5.46%
controls:1.62%
10
31
368
3739
7
8
372
3768
—
—
—
6
15
363
3708
19
56
329
3391
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
N02AX02 [21604298]
7.8e-01
9.7e-01
—
—
1.5e+00
8.9e-01
7.8e-01
cases:12.96%
controls:6.42%
cases:5.54%
controls:2.17%
—
—
—
—
cases:1.59%
controls:0.37%
cases:6.23%
controls:2.66%
cases:13.79%
controls:6.85%
49
242
329
3528
21
82
358
3694
—
—
6
14
371
3759
23
99
346
3624
48
236
300
3211
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
4.2e-01
2.9e-01
1.2e+00
—
1.6e+00
1.1e+00
6.2e-01
cases:7.14%
controls:4.83%
cases:3.69%
controls:2.78%
cases:1.58%
controls:0.50%
—
—
cases:2.39%
controls:0.48%
cases:8.13%
controls:2.93%
cases:16.67%
controls:9.72%
27
182
351
3588
14
105
365
3671
6
19
373
3757
—
9
18
368
3755
30
109
339
3614
58
335
290
3112
Stomach Pathology biopsy report
66114-0 [40768797]
66114-0 [40768797]
5.9e-01
2.1e+00
—
—
—
—
9.2e-01
cases:1.85%
controls:1.03%
cases:1.85%
controls:0.24%
—
—
—
—
—
—
—
—
cases:5.17%
controls:2.12%
7
39
371
3731
7
9
372
3767
—
—
—
—
18
73
330
3374
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2039-6 [3003785]
2039-6 [3003785]
—
1.3e+00
—
—
—
1.6e+00
1.3e+00
—
—
cases:2.11%
controls:0.56%
—
—
—
—
—
—
cases:3.25%
controls:0.64%
cases:5.46%
controls:1.57%
—
8
21
371
3755
—
—
—
12
24
357
3699
19
54
329
3393
Intestinal adhesions [bands] with obstruction
K56.5 [45601181]
K56.5 [45601181]
—
—
—
1.0e+50
—
—
2.9e+00
—
—
—
—
—
—
cases:1.58%
controls:0.00%
—
—
—
—
cases:2.59%
controls:0.15%
—
—
—
6
0
373
3776
—
—
9
5
339
3442
Physiotherapist
Z3226 [2001311560]
Z3226 [2001311560]
9.9e-01
9.9e-01
—
—
—
1.9e+00
9.5e-01
cases:6.88%
controls:2.68%
cases:2.11%
controls:0.79%
—
—
—
—
—
—
cases:4.61%
controls:0.73%
cases:4.60%
controls:1.83%
26
101
352
3669
8
30
371
3746
—
—
—
17
27
352
3696
16
63
332
3384
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
8.2e-01
4.4e-01
—
1.0e+50
—
1.1e+00
8.7e-01
cases:11.64%
controls:5.46%
cases:2.64%
controls:1.72%
—
—
cases:4.49%
controls:0.00%
—
—
cases:4.88%
controls:1.69%
cases:11.78%
controls:5.31%
44
206
334
3564
10
65
369
3711
—
17
0
362
3776
—
18
63
351
3660
41
183
307
3264
Tissue Pathology biopsy report
66121-5 [40768804]
66121-5 [40768804]
4.4e-01
8.6e-01
—
—
2.1e+00
6.1e-01
6.1e-01
cases:6.08%
controls:4.01%
cases:2.90%
controls:1.24%
—
—
—
—
cases:2.12%
controls:0.27%
cases:3.25%
controls:1.80%
cases:11.78%
controls:6.76%
23
151
355
3619
11
47
368
3729
—
—
8
10
369
3763
12
67
357
3656
41
233
307
3214
Intravenous general anesthesia
WX404 [2001310807]
WX404 [2001310807]
7.4e-01
8.2e-01
—
—
—
1.5e+00
1.2e+00
cases:5.29%
controls:2.60%
cases:1.85%
controls:0.82%
—
—
—
—
—
—
cases:2.71%
controls:0.64%
cases:7.18%
controls:2.20%
20
98
358
3672
7
31
372
3745
—
—
—
10
24
359
3699
25
76
323
3371
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
2.2e-01
4.0e-01
1.3e+00
—
1.4e+00
2.9e-01
1.5e-01
cases:20.37%
controls:17.00%
cases:19.26%
controls:13.74%
cases:8.71%
controls:2.65%
—
—
cases:9.28%
controls:2.54%
cases:20.33%
controls:16.04%
cases:44.54%
controls:40.99%
77
641
301
3129
73
519
306
3257
33
100
346
3676
—
35
96
342
3677
75
597
294
3126
155
1413
193
2034
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
3.6e-01
2.6e-01
—
—
1.8e+00
8.4e-01
3.7e-01
cases:7.67%
controls:5.46%
cases:4.22%
controls:3.28%
—
—
—
—
cases:2.92%
controls:0.50%
cases:7.59%
controls:3.44%
cases:16.38%
controls:11.87%
29
206
349
3564
16
124
363
3652
—
—
11
19
366
3754
28
128
341
3595
57
409
291
3038
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
J01MA12 [21603019]
7.0e-01
1.3e+00
—
—
—
1.5e+00
1.0e+00
cases:3.70%
controls:1.88%
cases:1.85%
controls:0.50%
—
—
—
—
—
—
cases:2.44%
controls:0.54%
cases:5.17%
controls:1.91%
14
71
364
3699
7
19
372
3757
—
—
—
9
20
360
3703
18
66
330
3381
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
1.9e-01
3.2e-01
1.3e+00
1.0e+50
1.2e+00
5.5e-01
4.4e-01
cases:6.08%
controls:5.07%
cases:5.28%
controls:3.89%
cases:3.96%
controls:1.06%
cases:2.11%
controls:0.00%
cases:3.45%
controls:1.06%
cases:7.05%
controls:4.19%
cases:13.79%
controls:9.37%
23
191
355
3579
20
147
359
3629
15
40
364
3736
8
0
371
3776
13
40
364
3733
26
156
343
3567
48
323
300
3124
Malignant tumour
130 [2001600128]
130 [2001600128]
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
cases:1.63%
controls:0.13%
—
—
—
—
—
—
—
6
5
363
3718
—
Diverticular disease of intestine, part unspecified, without perforation or abscess
K57.9 [45543325]
K57.9 [45543325]
2.5e+00
—
—
—
—
—
—
cases:1.59%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
6
5
372
3765
—
—
—
—
—
—
Oncology Clinic/Center
261QX0200X [38004268]
261QX0200X [38004268]
1.1e-01
7.0e-01
2.5e+00
—
—
5.9e-01
6.4e-01
cases:4.76%
controls:4.27%
cases:1.85%
controls:0.93%
cases:1.58%
controls:0.13%
—
—
—
—
cases:2.17%
controls:1.21%
cases:6.61%
controls:3.60%
18
161
360
3609
7
35
372
3741
6
5
373
3771
—
—
8
45
361
3678
23
124
325
3323
Heartburn
R12 [45539318]
R12 [45539318]
—
2.5e+00
—
—
—
—
—
—
—
cases:1.58%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
6
5
373
3771
—
—
—
—
—
Diverticular disease of intestine
K57 [45755438]
K57 [45755438]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.72%
controls:0.15%
—
—
—
—
—
—
6
5
342
3442
Psychiatry
26 [38004469]
26 [38004469]
6.4e-01
6.8e-01
1.4e+00
—
1.1e+00
1.1e+00
6.0e-01
cases:8.20%
controls:4.48%
cases:3.96%
controls:2.04%
cases:2.90%
controls:0.74%
—
—
cases:2.39%
controls:0.85%
cases:6.23%
controls:2.26%
cases:8.05%
controls:4.58%
31
169
347
3601
15
77
364
3699
11
28
368
3748
—
9
32
368
3741
23
84
346
3639
28
158
320
3289
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
3.5e-01
4.1e-01
1.2e+00
—
1.2e+00
4.9e-01
1.1e-01
cases:17.20%
controls:12.81%
cases:10.55%
controls:7.28%
cases:3.43%
controls:1.06%
—
—
cases:3.71%
controls:1.11%
cases:12.20%
controls:7.87%
cases:21.84%
controls:20.02%
65
483
313
3287
40
275
339
3501
13
40
366
3736
—
14
42
363
3731
45
293
324
3430
76
690
272
2757
Implantation of vascular injection port
TPX10 [2001309608]
TPX10 [2001309608]
-1.0e+50
—
—
—
—
2.3e+00
2.3e+00
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
cases:1.36%
controls:0.13%
cases:1.44%
controls:0.15%
0
14
378
3756
—
—
—
—
5
5
364
3718
5
5
343
3442
Difficulties in perfomrming procedure
ZXD30 [2001311389]
ZXD30 [2001311389]
-1.0e+50
—
—
—
—
2.3e+00
—
cases:0.00%
controls:0.42%
—
—
—
—
—
—
—
—
cases:1.36%
controls:0.13%
—
—
0
16
378
3754
—
—
—
—
5
5
364
3718
—
Other specified counselling
Z71.8 [45581061]
Z71.8 [45581061]
6.5e-01
7.5e-01
—
—
2.3e+00
7.0e-01
6.2e-01
cases:3.97%
controls:2.12%
cases:2.11%
controls:1.01%
—
—
—
—
cases:1.59%
controls:0.16%
cases:2.71%
controls:1.37%
cases:8.91%
controls:5.02%
15
80
363
3690
8
38
371
3738
—
—
6
6
371
3767
10
51
359
3672
31
173
317
3274
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
5794-3 [3011397]
7.4e-01
9.8e-01
2.3e+00
—
—
5.3e-01
-8.2e-02
cases:3.70%
controls:1.80%
cases:2.64%
controls:1.01%
cases:1.58%
controls:0.16%
—
—
—
—
cases:2.98%
controls:1.77%
cases:5.75%
controls:6.21%
14
68
364
3702
10
38
369
3738
6
6
373
3770
—
—
11
66
358
3657
20
214
328
3233
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
7.4e-01
8.8e-01
—
1.0e+50
—
6.3e-01
6.8e-01
cases:12.17%
controls:6.18%
cases:6.33%
controls:2.73%
—
—
cases:2.64%
controls:0.00%
—
—
cases:4.88%
controls:2.66%
cases:14.37%
controls:7.86%
46
233
332
3537
24
103
355
3673
—
10
0
369
3776
—
18
99
351
3624
50
271
298
3176
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
77397-8 [46236098]
5.0e-01
5.1e-01
—
1.0e+50
—
1.4e+00
8.6e-01
cases:3.44%
controls:2.12%
cases:1.85%
controls:1.11%
—
—
cases:1.85%
controls:0.00%
—
—
cases:3.52%
controls:0.89%
cases:8.91%
controls:3.97%
13
80
365
3690
7
42
372
3734
—
7
0
372
3776
—
13
33
356
3690
31
137
317
3310
Low back pain
M54.5 [45553207]
M54.5 [45553207]
7.0e-01
1.1e+00
2.0e+00
—
—
1.2e+00
5.8e-01
cases:6.88%
controls:3.55%
cases:3.43%
controls:1.17%
cases:1.32%
controls:0.19%
—
—
—
—
cases:4.61%
controls:1.50%
cases:10.92%
controls:6.41%
26
134
352
3636
13
44
366
3732
5
7
374
3769
—
—
17
56
352
3667
38
221
310
3226
Abdominal CT examination
JN3AD [2001305554]
JN3AD [2001305554]
—
—
—
1.0e+50
—
2.2e+00
9.2e-01
—
—
—
—
—
—
cases:2.90%
controls:0.00%
—
—
cases:2.71%
controls:0.30%
cases:2.87%
controls:1.16%
—
—
—
11
0
368
3776
—
10
11
359
3712
10
40
338
3407
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
A03FA01 [21600484]
5.6e-01
6.1e-01
—
—
—
1.2e+00
1.0e+00
cases:5.03%
controls:2.94%
cases:2.64%
controls:1.46%
—
—
—
—
—
—
cases:4.34%
controls:1.32%
cases:7.76%
controls:2.96%
19
111
359
3659
10
55
369
3721
—
—
—
16
49
353
3674
27
102
321
3345
Tension-type headache
G44.2 [45581495]
G44.2 [45581495]
9.8e-01
2.2e+00
—
—
—
1.1e+00
6.5e-01
cases:3.17%
controls:1.22%
cases:2.37%
controls:0.26%
—
—
—
—
—
—
cases:1.63%
controls:0.56%
cases:3.45%
controls:1.83%
12
46
366
3724
9
10
370
3766
—
—
—
6
21
363
3702
12
63
336
3384
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
24357-6 [3037467]
5.1e-01
7.7e-01
1.3e+00
—
1.4e+00
5.7e-01
3.0e-01
cases:13.76%
controls:8.78%
cases:8.71%
controls:4.24%
cases:2.64%
controls:0.72%
—
—
cases:2.65%
controls:0.66%
cases:8.94%
controls:5.24%
cases:22.41%
controls:17.70%
52
331
326
3439
33
160
346
3616
10
27
369
3749
—
10
25
367
3748
33
195
336
3528
78
610
270
2837
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
22664-7 [3020779]
—
7.8e-01
—
—
2.2e+00
1.2e+00
6.9e-01
—
—
cases:1.32%
controls:0.61%
—
—
—
—
cases:1.59%
controls:0.19%
cases:2.17%
controls:0.64%
cases:3.74%
controls:1.91%
—
5
23
374
3753
—
—
6
7
371
3766
8
24
361
3699
13
66
335
3381
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
14879-1 [3003458]
3.0e-01
7.3e-01
—
—
2.2e+00
2.8e-01
6.6e-01
cases:1.85%
controls:1.38%
cases:1.85%
controls:0.90%
—
—
—
—
cases:1.59%
controls:0.19%
cases:1.63%
controls:1.24%
cases:5.46%
controls:2.90%
7
52
371
3718
7
34
372
3742
—
—
6
7
371
3766
6
46
363
3677
19
100
329
3347
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
3.4e-01
4.6e-01
1.5e+00
—
7.3e-01
6.6e-01
3.2e-01
cases:9.52%
controls:6.98%
cases:7.65%
controls:4.98%
cases:4.75%
controls:1.11%
—
—
cases:3.18%
controls:1.56%
cases:9.76%
controls:5.29%
cases:17.53%
controls:13.34%
36
263
342
3507
29
188
350
3588
18
42
361
3734
—
12
59
365
3714
36
197
333
3526
61
460
287
2987
codeine and paracetamol
N02AJ06 [1123647]
N02AJ06 [1123647]
5.9e-01
8.5e-01
4.8e-01
—
—
7.1e-01
3.6e-01
cases:19.58%
controls:11.91%
cases:10.55%
controls:4.82%
cases:1.32%
controls:0.82%
—
—
—
—
cases:9.49%
controls:4.92%
cases:18.68%
controls:13.87%
74
449
304
3321
40
182
339
3594
5
31
374
3745
—
—
35
183
334
3540
65
478
283
2969
Other and unspecified ventral hernia without obstruction or gangrene
K43.9 [45533594]
K43.9 [45533594]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.87%
controls:0.35%
—
—
—
—
—
—
10
12
338
3435
Repeated or continuing anesthesia shots throug a catheter
WX602 [2001310813]
WX602 [2001310813]
—
—
—
1.0e+50
—
2.0e+00
1.6e+00
—
—
—
—
—
—
cases:1.85%
controls:0.00%
—
—
cases:1.63%
controls:0.21%
cases:2.30%
controls:0.49%
—
—
—
7
0
372
3776
—
6
8
363
3715
8
17
340
3430
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
4.1e-01
7.6e-01
—
1.0e+50
2.0e+00
8.1e-01
5.9e-01
cases:3.44%
controls:2.31%
cases:3.17%
controls:1.51%
—
—
cases:2.64%
controls:0.00%
cases:2.39%
controls:0.32%
cases:3.79%
controls:1.72%
cases:9.48%
controls:5.51%
13
87
365
3683
12
57
367
3719
—
10
0
369
3776
9
12
368
3761
14
64
355
3659
33
190
315
3257
Urinary tract ultrasound examination
KH1AE [2001306329]
KH1AE [2001306329]
2.0e+00
—
—
—
—
—
—
cases:1.59%
controls:0.21%
—
—
—
—
—
—
—
—
—
—
—
—
6
8
372
3762
—
—
—
—
—
—
azathioprine; oral, parenteral
L04AX01 [21603927]
L04AX01 [21603927]
1.4e+00
2.0e+00
—
—
—
1.6e+00
1.3e+00
cases:1.59%
controls:0.40%
cases:1.58%
controls:0.21%
—
—
—
—
—
—
cases:1.63%
controls:0.32%
cases:2.01%
controls:0.58%
6
15
372
3755
6
8
373
3768
—
—
—
6
12
363
3711
7
20
341
3427
pregabalin; oral
N02BF02 [955152]
N02BF02 [955152]
2.5e-01
1.8e-01
—
—
—
1.2e+00
7.9e-01
cases:5.03%
controls:3.95%
cases:2.37%
controls:1.99%
—
—
—
—
—
—
cases:5.42%
controls:1.67%
cases:8.62%
controls:4.09%
19
149
359
3621
9
75
370
3701
—
—
—
20
62
349
3661
30
141
318
3306
Remowal of suture of skin
TQW40 [2001310146]
TQW40 [2001310146]
2.0e+00
-1.0e+50
—
—
—
—
—
cases:2.12%
controls:0.29%
cases:0.00%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
8
11
370
3759
0
7
379
3769
—
—
—
—
—
Iron deficiency anaemia, unspecified
D50.9 [45605373]
D50.9 [45605373]
1.2e+00
2.0e+00
—
—
—
—
9.9e-01
cases:2.12%
controls:0.64%
cases:2.11%
controls:0.29%
—
—
—
—
—
—
—
—
cases:2.30%
controls:0.87%
8
24
370
3746
8
11
371
3765
—
—
—
—
8
30
340
3417
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1920-8 [3013721]
-1.0e-01
4.6e-01
—
—
2.0e+00
7.2e-01
2.6e-01
cases:3.44%
controls:3.79%
cases:3.17%
controls:2.01%
—
—
—
—
cases:1.86%
controls:0.27%
cases:4.07%
controls:2.01%
cases:9.77%
controls:7.69%
13
143
365
3627
12
76
367
3700
—
—
7
10
370
3763
15
75
354
3648
34
265
314
3182
macrogol; oral
A06AD15 [21600575]
A06AD15 [21600575]
1.0e+00
—
—
—
—
2.0e+00
-1.2e-01
cases:1.59%
controls:0.58%
—
—
—
—
—
—
—
—
cases:3.52%
controls:0.51%
cases:1.72%
controls:1.94%
6
22
372
3748
—
—
—
—
13
19
356
3704
6
67
342
3380
dalteparin; parenteral
B01AB04 [21600975]
B01AB04 [21600975]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.01%
controls:0.29%
—
—
—
—
—
—
7
10
341
3437
desloratadine; oral
R06AX27 [21603526]
R06AX27 [21603526]
6.0e-01
9.6e-01
—
—
—
6.9e-01
9.9e-01
cases:7.41%
controls:4.22%
cases:5.01%
controls:1.99%
—
—
—
—
—
—
cases:3.25%
controls:1.67%
cases:10.92%
controls:4.35%
28
159
350
3611
19
75
360
3701
—
—
—
12
62
357
3661
38
150
310
3297
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4537-7 [3013707]
3.4e-01
5.6e-01
1.3e+00
—
—
6.5e-01
1.7e-01
cases:12.70%
controls:9.39%
cases:9.50%
controls:5.67%
cases:2.90%
controls:0.82%
—
—
—
—
cases:11.11%
controls:6.10%
cases:23.85%
controls:20.95%
48
354
330
3416
36
214
343
3562
11
31
368
3745
—
—
41
227
328
3496
83
722
265
2725
calcium (different salts in combination); oral
A12AA20 [21600872]
A12AA20 [21600872]
6.1e-01
7.0e-01
6.9e-01
—
6.0e-01
5.6e-01
6.3e-01
cases:13.23%
controls:7.67%
cases:10.29%
controls:5.38%
cases:3.43%
controls:1.75%
—
—
cases:2.39%
controls:1.33%
cases:10.30%
controls:6.15%
cases:16.38%
controls:9.49%
50
289
328
3481
39
203
340
3573
13
66
366
3710
—
9
50
368
3723
38
229
331
3494
57
327
291
3120
sumatriptan; nasal, oral, parenteral, rectal
N02CC01 [21604376]
N02CC01 [21604376]
9.7e-01
1.1e+00
—
—
1.4e+00
8.5e-01
9.5e-01
cases:5.82%
controls:2.28%
cases:2.90%
controls:1.01%
—
—
—
—
cases:1.33%
controls:0.32%
cases:2.71%
controls:1.18%
cases:4.89%
controls:1.94%
22
86
356
3684
11
38
368
3738
—
—
5
12
372
3761
10
44
359
3679
17
67
331
3380
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
30248-9 [3015399]
6.8e-01
8.0e-01
—
—
—
1.1e+00
8.3e-01
cases:4.50%
controls:2.33%
cases:2.90%
controls:1.32%
—
—
—
—
—
—
cases:3.52%
controls:1.21%
cases:10.06%
controls:4.64%
17
88
361
3682
11
50
368
3726
—
—
—
13
45
356
3678
35
160
313
3287
Bicarbonate [Moles/volume] standard in Capillary blood
19231-0 [3004490]
19231-0 [3004490]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.16%
controls:0.49%
—
—
—
—
—
—
11
17
337
3430
Throat symptom/complaint
R21 [2002000891]
R21 [2002000891]
1.0e+00
7.9e-01
—
—
—
8.5e-01
8.4e-01
cases:5.29%
controls:1.94%
cases:1.85%
controls:0.85%
—
—
—
—
—
—
cases:2.17%
controls:0.94%
cases:6.32%
controls:2.84%
20
73
358
3697
7
32
372
3744
—
—
—
8
35
361
3688
22
98
326
3349
topiramate; oral
N03AX11 [21604433]
N03AX11 [21604433]
1.9e+00
—
—
—
—
—
—
cases:1.85%
controls:0.29%
—
—
—
—
—
—
—
—
—
—
—
—
7
11
371
3759
—
—
—
—
—
—
Clinic/Center
261Q00000X [38004207]
261Q00000X [38004207]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.01%
controls:0.32%
—
—
—
—
—
—
7
11
341
3436
Dysuria
R30.0 [45592416]
R30.0 [45592416]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.01%
controls:0.32%
—
—
—
—
—
—
7
11
341
3436
Emergency care or similar visit
WYA10 [2001310872]
WYA10 [2001310872]
1.8e+00
—
—
—
—
—
—
cases:2.12%
controls:0.34%
—
—
—
—
—
—
—
—
—
—
—
—
8
13
370
3757
—
—
—
—
—
—
pH of Urine
2756-5 [3015736]
2756-5 [3015736]
5.4e-01
9.3e-01
1.8e+00
—
1.2e+00
4.8e-01
7.4e-02
cases:6.88%
controls:4.14%
cases:4.49%
controls:1.83%
cases:2.11%
controls:0.34%
—
—
cases:1.33%
controls:0.40%
cases:4.88%
controls:3.06%
cases:12.36%
controls:11.58%
26
156
352
3614
17
69
362
3707
8
13
371
3763
—
5
15
372
3758
18
114
351
3609
43
399
305
3048
Other specified special examinations
Z01.8 [45581003]
Z01.8 [45581003]
9.6e-01
8.9e-01
—
—
—
9.4e-01
8.7e-01
cases:5.82%
controls:2.31%
cases:1.85%
controls:0.77%
—
—
—
—
—
—
cases:2.17%
controls:0.86%
cases:7.47%
controls:3.28%
22
87
356
3683
7
29
372
3747
—
—
—
8
32
361
3691
26
113
322
3334
Teaching
WZC30 [2001310891]
WZC30 [2001310891]
2.7e-01
—
—
—
—
1.8e+00
3.0e-01
cases:1.32%
controls:1.01%
—
—
—
—
—
—
—
—
cases:2.44%
controls:0.40%
cases:3.16%
controls:2.35%
5
38
373
3732
—
—
—
—
9
15
360
3708
11
81
337
3366
doxycycline; oral, parenteral
J01AA02 [21602800]
J01AA02 [21602800]
5.9e-01
7.4e-01
1.2e+00
—
9.2e-01
3.9e-01
4.9e-01
cases:27.78%
controls:17.56%
cases:10.82%
controls:5.48%
cases:1.58%
controls:0.48%
—
—
cases:1.33%
controls:0.53%
cases:6.78%
controls:4.67%
cases:23.28%
controls:15.67%
105
662
273
3108
41
207
338
3569
6
18
373
3758
—
5
20
372
3753
25
174
344
3549
81
540
267
2907
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
8.0e-01
5.3e-01
—
1.0e+50
—
1.0e+00
3.7e-01
cases:8.20%
controls:3.87%
cases:2.64%
controls:1.56%
—
—
cases:1.32%
controls:0.00%
—
—
cases:4.34%
controls:1.61%
cases:6.32%
controls:4.44%
31
146
347
3624
10
59
369
3717
—
5
0
374
3776
—
16
60
353
3663
22
153
326
3294
Acromioplastia, arthroscopic
NBG15 [2001307302]
NBG15 [2001307302]
1.8e+00
—
—
—
—
-1.0e+50
—
cases:2.65%
controls:0.45%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.16%
—
—
10
17
368
3753
—
—
—
—
0
6
369
3717
—
fluocortolone
C05AA08 [21601612]
C05AA08 [21601612]
1.0e+00
—
—
—
—
1.8e+00
4.0e-01
cases:3.17%
controls:1.17%
—
—
—
—
—
—
—
—
cases:1.90%
controls:0.32%
cases:2.01%
controls:1.36%
12
44
366
3726
—
—
—
—
7
12
362
3711
7
47
341
3400
Sciatica
M54.3 [45586994]
M54.3 [45586994]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.87%
controls:0.49%
—
—
—
—
—
—
10
17
338
3430
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
M01AE01 [21603967]
3.8e-01
3.4e-01
-1.3e-01
—
1.4e+00
3.7e-01
3.4e-01
cases:40.74%
controls:31.94%
cases:19.26%
controls:14.46%
cases:1.85%
controls:2.09%
—
—
cases:7.43%
controls:1.96%
cases:19.51%
controls:14.40%
cases:42.24%
controls:34.15%
154
1204
224
2566
73
546
306
3230
7
79
372
3697
—
28
74
349
3699
72
536
297
3187
147
1177
201
2270
ibuprofen
R02AX02 [1588667]
R02AX02 [1588667]
3.8e-01
3.4e-01
-1.3e-01
—
1.4e+00
3.7e-01
3.4e-01
cases:40.74%
controls:31.94%
cases:19.26%
controls:14.46%
cases:1.85%
controls:2.09%
—
—
cases:7.43%
controls:1.96%
cases:19.51%
controls:14.40%
cases:42.24%
controls:34.15%
154
1204
224
2566
73
546
306
3230
7
79
372
3697
—
28
74
349
3699
72
536
297
3187
147
1177
201
2270
Atrial fibrillation and flutter
I48 [45596206]
I48 [45596206]
3.9e-01
6.4e-01
1.8e+00
—
1.3e+00
4.5e-01
5.2e-01
cases:5.03%
controls:3.45%
cases:3.69%
controls:1.99%
cases:2.11%
controls:0.37%
—
—
cases:1.33%
controls:0.37%
cases:3.52%
controls:2.28%
cases:8.33%
controls:5.13%
19
130
359
3640
14
75
365
3701
8
14
371
3762
—
5
14
372
3759
13
85
356
3638
29
177
319
3270
Short blood count panel - Blood
55429-5 [40758558]
55429-5 [40758558]
2.8e-01
2.4e-01
1.8e+00
—
—
5.9e-01
6.0e-01
cases:4.50%
controls:3.42%
cases:2.37%
controls:1.88%
cases:2.11%
controls:0.37%
—
—
—
—
cases:3.52%
controls:1.99%
cases:9.48%
controls:5.43%
17
129
361
3641
9
71
370
3705
8
14
371
3762
—
—
13
74
356
3649
33
187
315
3260
Norovirus RNA [Presence] in Stool by NAA with probe detection
7974-9 [3008909]
7974-9 [3008909]
—
—
—
—
—
-1.0e+50
1.8e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.16%
cases:2.30%
controls:0.41%
—
—
—
—
—
0
6
369
3717
8
14
340
3433
12 lead EKG panel
34534-8 [3044889]
34534-8 [3044889]
1.9e-02
6.1e-01
1.2e+00
—
1.7e+00
-6.4e-02
4.4e-02
cases:9.26%
controls:9.10%
cases:8.18%
controls:4.63%
cases:1.85%
controls:0.58%
—
—
cases:2.65%
controls:0.48%
cases:5.69%
controls:6.04%
cases:20.98%
controls:20.25%
35
343
343
3427
31
175
348
3601
7
22
372
3754
—
10
18
367
3755
21
225
348
3498
73
698
275
2749
Sleep apnoea
G47.3 [45562094]
G47.3 [45562094]
5.7e-01
6.9e-01
—
—
—
1.0e+00
7.2e-01
cases:3.97%
controls:2.28%
cases:3.17%
controls:1.62%
—
—
—
—
—
—
cases:4.61%
controls:1.75%
cases:8.91%
controls:4.53%
15
86
363
3684
12
61
367
3715
—
—
—
17
65
352
3658
31
156
317
3291
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
JN1AE [2001305517]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.16%
controls:0.58%
—
—
—
—
—
—
11
20
337
3427
Flexible sigmoidoscopy with biopsy
UJF45 [2001305031]
UJF45 [2001305031]
1.1e+00
—
—
—
—
—
1.7e+00
cases:1.59%
controls:0.56%
—
—
—
—
—
—
—
—
—
—
cases:3.45%
controls:0.64%
6
21
372
3749
—
—
—
—
—
12
22
336
3425
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
2.7e-01
4.8e-01
1.7e+00
—
8.2e-01
5.7e-01
2.1e-01
cases:8.20%
controls:6.39%
cases:6.07%
controls:3.84%
cases:3.43%
controls:0.66%
—
—
cases:2.39%
controls:1.06%
cases:7.59%
controls:4.46%
cases:14.08%
controls:11.72%
31
241
347
3529
23
145
356
3631
13
25
366
3751
—
9
40
368
3733
28
166
341
3557
49
404
299
3043
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
2.7e-01
4.4e-01
1.7e+00
—
8.2e-01
5.3e-01
2.2e-01
cases:8.20%
controls:6.37%
cases:5.80%
controls:3.81%
cases:3.43%
controls:0.66%
—
—
cases:2.39%
controls:1.06%
cases:7.32%
controls:4.43%
cases:14.08%
controls:11.66%
31
240
347
3530
22
144
357
3632
13
25
366
3751
—
9
40
368
3733
27
165
342
3558
49
402
299
3045
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
26478-8 [3002030]
2.2e-01
4.8e-01
1.7e+00
—
9.0e-01
5.7e-01
2.5e-01
cases:7.94%
controls:6.47%
cases:5.80%
controls:3.68%
cases:3.69%
controls:0.72%
—
—
cases:2.39%
controls:0.98%
cases:7.59%
controls:4.43%
cases:14.66%
controls:11.84%
30
244
348
3526
22
139
357
3637
14
27
365
3749
—
9
37
368
3736
28
165
341
3558
51
408
297
3039
Monocytes/Leukocytes in Blood
26485-3 [3019069]
26485-3 [3019069]
3.1e-01
4.9e-01
1.7e+00
—
8.8e-01
5.6e-01
2.6e-01
cases:8.20%
controls:6.13%
cases:5.80%
controls:3.63%
cases:3.69%
controls:0.72%
—
—
cases:2.39%
controls:1.01%
cases:7.32%
controls:4.30%
cases:14.08%
controls:11.26%
31
231
347
3539
22
137
357
3639
14
27
365
3749
—
9
38
368
3735
27
160
342
3563
49
388
299
3059
Eosinophils [#/volume] in Blood
26449-9 [3013115]
26449-9 [3013115]
2.6e-01
4.3e-01
1.7e+00
—
5.9e-01
5.1e-01
1.9e-01
cases:8.73%
controls:6.84%
cases:6.07%
controls:4.03%
cases:3.96%
controls:0.77%
—
—
cases:2.12%
controls:1.19%
cases:7.59%
controls:4.70%
cases:14.37%
controls:12.16%
33
258
345
3512
23
152
356
3624
15
29
364
3747
—
8
45
369
3728
28
175
341
3548
50
419
298
3028
Migraine with aura [classical migraine]
G43.1 [45562086]
G43.1 [45562086]
1.6e+00
—
—
—
—
—
—
cases:2.12%
controls:0.42%
—
—
—
—
—
—
—
—
—
—
—
—
8
16
370
3754
—
—
—
—
—
—
Ultrasound measurement of residual urine
KC1EE [2001305918]
KC1EE [2001305918]
1.6e+00
1.4e+00
—
—
—
1.9e+00
9.5e-01
cases:3.44%
controls:0.72%
cases:1.32%
controls:0.34%
—
—
—
—
—
—
cases:1.63%
controls:0.24%
cases:3.16%
controls:1.25%
13
27
365
3743
5
13
374
3763
—
—
—
6
9
363
3714
11
43
337
3404
Basophils/Leukocytes in Blood
30180-4 [3022096]
30180-4 [3022096]
3.2e-01
5.3e-01
1.6e+00
—
9.8e-01
6.1e-01
2.6e-01
cases:8.20%
controls:6.10%
cases:6.07%
controls:3.68%
cases:3.43%
controls:0.72%
—
—
cases:2.65%
controls:1.01%
cases:7.59%
controls:4.27%
cases:14.08%
controls:11.20%
31
230
347
3540
23
139
356
3637
13
27
366
3749
—
10
38
367
3735
28
159
341
3564
49
386
299
3061
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
26474-7 [3019198]
2.6e-01
4.9e-01
1.6e+00
—
8.0e-01
5.9e-01
2.0e-01
cases:8.47%
controls:6.66%
cases:6.33%
controls:3.97%
cases:3.43%
controls:0.72%
—
—
cases:2.39%
controls:1.09%
cases:8.13%
controls:4.67%
cases:14.94%
controls:12.62%
32
251
346
3519
24
150
355
3626
13
27
366
3749
—
9
41
368
3732
30
174
339
3549
52
435
296
3012
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
26450-7 [3006504]
3.2e-01
5.2e-01
1.6e+00
—
9.8e-01
6.1e-01
2.6e-01
cases:8.20%
controls:6.10%
cases:6.07%
controls:3.71%
cases:3.43%
controls:0.72%
—
—
cases:2.65%
controls:1.01%
cases:7.59%
controls:4.27%
cases:14.08%
controls:11.26%
31
230
347
3540
23
140
356
3636
13
27
366
3749
—
10
38
367
3735
28
159
341
3564
49
388
299
3059
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
26511-6 [3018010]
1.6e-01
4.9e-01
1.6e+00
—
8.8e-01
6.0e-01
2.3e-01
cases:7.14%
controls:6.15%
cases:5.80%
controls:3.65%
cases:3.43%
controls:0.72%
—
—
cases:2.39%
controls:1.01%
cases:7.59%
controls:4.32%
cases:14.08%
controls:11.49%
27
232
351
3538
22
138
357
3638
13
27
366
3749
—
9
38
368
3735
28
161
341
3562
49
396
299
3051
Gas panel - Capillary blood
24337-8 [3022313]
24337-8 [3022313]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.45%
controls:0.73%
—
—
—
—
—
—
12
25
336
3422
Calprotectin [Mass/mass] in Stool
38445-3 [3048689]
38445-3 [3048689]
1.0e+00
1.6e+00
—
—
—
1.3e+00
7.6e-01
cases:3.17%
controls:1.19%
cases:2.90%
controls:0.61%
—
—
—
—
—
—
cases:2.44%
controls:0.67%
cases:4.60%
controls:2.20%
12
45
366
3725
11
23
368
3753
—
—
—
9
25
360
3698
16
76
332
3371
EKG study
11524-6 [3013512]
11524-6 [3013512]
1.2e-01
9.7e-01
—
—
—
5.5e-01
6.0e-01
cases:3.44%
controls:3.08%
cases:4.22%
controls:1.64%
—
—
—
—
—
—
cases:3.52%
controls:2.07%
cases:13.51%
controls:7.89%
13
116
365
3654
16
62
363
3714
—
—
—
13
77
356
3646
47
272
301
3175
loperamide oxide; oral
A07DA05 [21600648]
A07DA05 [21600648]
8.8e-01
1.6e+00
—
—
—
1.2e+00
1.6e+00
cases:1.59%
controls:0.66%
cases:1.32%
controls:0.26%
—
—
—
—
—
—
cases:1.63%
controls:0.48%
cases:3.74%
controls:0.81%
6
25
372
3745
5
10
374
3766
—
—
—
6
18
363
3705
13
28
335
3419
loperamide; oral
A07DA03 [21600646]
A07DA03 [21600646]
8.8e-01
1.6e+00
—
—
—
1.2e+00
1.6e+00
cases:1.59%
controls:0.66%
cases:1.32%
controls:0.26%
—
—
—
—
—
—
cases:1.63%
controls:0.48%
cases:3.74%
controls:0.81%
6
25
372
3745
5
10
374
3766
—
—
—
6
18
363
3705
13
28
335
3419
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
2705-2 [3024354]
4.5e-01
—
—
—
—
1.5e+00
-4.3e-02
cases:1.32%
controls:0.85%
—
—
—
—
—
—
—
—
cases:2.44%
controls:0.54%
cases:2.59%
controls:2.70%
5
32
373
3738
—
—
—
—
9
20
360
3703
9
93
339
3354
Abdominal ultrasound examination
JN3AE [2001305555]
JN3AE [2001305555]
1.5e+00
1.4e+00
—
1.0e+50
—
1.6e+00
6.1e-01
cases:3.70%
controls:0.85%
cases:1.85%
controls:0.45%
—
—
cases:1.85%
controls:0.00%
—
—
cases:1.90%
controls:0.40%
cases:2.59%
controls:1.42%
14
32
364
3738
7
17
372
3759
—
7
0
372
3776
—
7
15
362
3708
9
49
339
3398
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
1963-8 [3016293]
—
—
-1.0e+50
—
—
—
1.5e+00
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
cases:4.02%
controls:0.93%
—
—
0
5
379
3771
—
—
—
14
32
334
3415
Gastro-oesophageal reflux disease without oesophagitis
K21.9 [45538509]
K21.9 [45538509]
7.0e-01
—
—
—
—
—
1.5e+00
cases:1.85%
controls:0.93%
—
—
—
—
—
—
—
—
—
—
cases:4.02%
controls:0.93%
7
35
371
3735
—
—
—
—
—
14
32
334
3415
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
51485-1 [3030306]
9.5e-01
8.4e-01
—
—
2.1e+00
1.5e+00
3.4e-01
cases:2.91%
controls:1.14%
cases:1.58%
controls:0.69%
—
—
—
—
cases:1.33%
controls:0.16%
cases:3.25%
controls:0.75%
cases:4.02%
controls:2.90%
11
43
367
3727
6
26
373
3750
—
—
5
6
372
3767
12
28
357
3695
14
100
334
3347
Cathetrisation of artery
TPH07 [2001309747]
TPH07 [2001309747]
1.1e+00
—
—
1.0e+50
—
1.8e+00
1.5e+00
cases:2.12%
controls:0.69%
—
—
—
—
cases:1.58%
controls:0.00%
—
—
cases:1.63%
controls:0.27%
cases:4.02%
controls:0.96%
8
26
370
3744
—
—
6
0
373
3776
—
6
10
363
3713
14
33
334
3414
Stomatognathic treatment, simple
SHA01 [2001310405]
SHA01 [2001310405]
5.1e-01
—
—
—
—
—
1.5e+00
cases:1.32%
controls:0.80%
—
—
—
—
—
—
—
—
—
—
cases:4.02%
controls:0.96%
5
30
373
3740
—
—
—
—
—
14
33
334
3414
Trochanteric bursitis
M70.6 [45606304]
M70.6 [45606304]
1.4e+00
—
—
—
—
—
9.3e-01
cases:3.17%
controls:0.80%
—
—
—
—
—
—
—
—
—
—
cases:4.31%
controls:1.74%
12
30
366
3740
—
—
—
—
—
15
60
333
3387
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
6.4e-01
6.6e-01
—
1.0e+50
—
1.4e+00
1.9e-01
cases:3.17%
controls:1.70%
cases:1.32%
controls:0.69%
—
—
cases:3.43%
controls:0.00%
—
—
cases:2.98%
controls:0.75%
cases:3.16%
controls:2.64%
12
64
366
3706
5
26
374
3750
—
13
0
366
3776
—
11
28
358
3695
11
91
337
3356
Pulmonary Disease
29 [38004472]
29 [38004472]
2.8e-01
7.7e-01
—
—
7.7e-01
6.9e-01
6.1e-01
cases:8.99%
controls:6.98%
cases:6.60%
controls:3.15%
—
—
—
—
cases:1.59%
controls:0.74%
cases:6.78%
controls:3.52%
cases:13.51%
controls:7.80%
34
263
344
3507
25
119
354
3657
—
—
6
28
371
3745
25
131
344
3592
47
269
301
3178
Headache
R51.80 [2000503603]
R51.80 [2000503603]
4.5e-01
—
—
—
—
9.8e-01
1.4e+00
cases:1.85%
controls:1.19%
—
—
—
—
—
—
—
—
cases:1.36%
controls:0.51%
cases:6.61%
controls:1.77%
7
45
371
3725
—
—
—
—
5
19
364
3704
23
61
325
3386
Bacterial infection, unspecified
A49.9 [45590816]
A49.9 [45590816]
1.1e+00
—
—
—
—
1.1e+00
1.4e+00
cases:1.85%
controls:0.61%
—
—
—
—
—
—
—
—
cases:1.36%
controls:0.46%
cases:4.60%
controls:1.22%
7
23
371
3747
—
—
—
—
5
17
364
3706
16
42
332
3405
Periodontal treatment by dental hygienist, very extensive
SDE04 [2001310352]
SDE04 [2001310352]
1.4e+00
-1.0e+50
—
—
—
—
—
cases:2.91%
controls:0.77%
cases:0.00%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
11
29
367
3741
0
7
379
3769
—
—
—
—
—
Uroflowmetry
44856007 [4261340]
44856007 [4261340]
1.3e+00
—
—
—
—
1.5e+00
6.6e-01
cases:3.97%
controls:1.09%
—
—
—
—
—
—
—
—
cases:1.36%
controls:0.30%
cases:2.87%
controls:1.51%
15
41
363
3729
—
—
—
—
5
11
364
3712
10
52
338
3395
Examination and observation for other specified reasons
Z04.8 [45552063]
Z04.8 [45552063]
1.3e+00
—
—
—
—
1.4e+00
1.0e+00
cases:2.91%
controls:0.80%
—
—
—
—
—
—
—
—
cases:1.36%
controls:0.35%
cases:3.74%
controls:1.36%
11
30
367
3740
—
—
—
—
5
13
364
3710
13
47
335
3400
Gastro-oesophageal reflux disease with oesophagitis
K21.0 [45543296]
K21.0 [45543296]
1.3e+00
—
—
—
—
—
4.0e-01
cases:3.17%
controls:0.88%
—
—
—
—
—
—
—
—
—
—
cases:2.01%
controls:1.36%
12
33
366
3737
—
—
—
—
—
7
47
341
3400
Treatment plan or consultation
WZC00 [2001310885]
WZC00 [2001310885]
2.2e-01
5.3e-01
—
—
—
1.3e+00
3.2e-01
cases:4.50%
controls:3.63%
cases:2.90%
controls:1.72%
—
—
—
—
—
—
cases:4.88%
controls:1.37%
cases:8.33%
controls:6.18%
17
137
361
3633
11
65
368
3711
—
—
—
18
51
351
3672
29
213
319
3234
Supine thorax X-ray examination
GD1QA [2001303648]
GD1QA [2001303648]
1.3e+00
—
—
—
—
—
7.6e-01
cases:3.44%
controls:0.95%
—
—
—
—
—
—
—
—
—
—
cases:4.31%
controls:2.06%
13
36
365
3734
—
—
—
—
—
15
71
333
3376
pH of Capillary blood
2745-8 [3009343]
2745-8 [3009343]
—
—
—
—
—
—
1.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.74%
controls:1.04%
—
—
—
—
—
—
13
36
335
3411
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
2020-6 [3023024]
—
—
—
—
—
—
1.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.74%
controls:1.04%
—
—
—
—
—
—
13
36
335
3411
Periodontitis pronounced
K05.31 [2000502729]
K05.31 [2000502729]
1.3e+00
—
—
—
—
—
4.7e-01
cases:2.91%
controls:0.82%
—
—
—
—
—
—
—
—
—
—
cases:2.59%
controls:1.62%
11
31
367
3739
—
—
—
—
—
9
56
339
3391
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
R29.8 [45587505]
1.3e+00
—
—
—
—
—
4.7e-01
cases:2.91%
controls:0.82%
—
—
—
—
—
—
—
—
—
—
cases:1.44%
controls:0.90%
11
31
367
3739
—
—
—
—
—
5
31
343
3416
Administration of medicine
SPAT1254 [2001700355]
SPAT1254 [2001700355]
1.3e+00
1.2e+00
—
—
—
1.1e+00
5.5e-01
cases:4.50%
controls:1.33%
cases:2.64%
controls:0.85%
—
—
—
—
—
—
cases:2.44%
controls:0.86%
cases:4.89%
controls:2.87%
17
50
361
3720
10
32
369
3744
—
—
—
9
32
360
3691
17
99
331
3348
Other specified chronic obstructive pulmonary disease
J44.8 [45586673]
J44.8 [45586673]
1.3e+00
—
—
—
-1.0e+50
9.3e-01
9.1e-01
cases:3.44%
controls:1.01%
—
—
—
—
—
—
cases:0.00%
controls:0.21%
cases:1.63%
controls:0.64%
cases:3.45%
controls:1.42%
13
38
365
3732
—
—
—
0
8
377
3765
6
24
363
3699
12
49
336
3398
Loss of teeth due to accident, extraction or local periodontal disease
K08.1 [45591573]
K08.1 [45591573]
—
—
—
—
—
—
1.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.45%
controls:1.02%
—
—
—
—
—
—
12
35
336
3412
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
24351-9 [3004588]
9.7e-01
—
—
—
—
—
1.2e+00
cases:1.32%
controls:0.50%
—
—
—
—
—
—
—
—
—
—
cases:3.45%
controls:1.02%
5
19
373
3751
—
—
—
—
—
12
35
336
3412
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
7.1e-01
—
1.4e+00
1.0e+50
1.7e+00
1.2e+00
5.7e-01
cases:4.50%
controls:2.25%
—
—
cases:1.32%
controls:0.32%
cases:2.64%
controls:0.00%
cases:1.33%
controls:0.24%
cases:3.79%
controls:1.15%
cases:8.05%
controls:4.73%
17
85
361
3685
—
5
12
374
3764
10
0
369
3776
5
9
372
3764
14
43
355
3680
28
163
320
3284
Removal of sutures
SPAT1153 [2001700254]
SPAT1153 [2001700254]
5.8e-01
7.7e-01
—
—
—
1.2e+00
3.4e-01
cases:5.29%
controls:3.02%
cases:1.58%
controls:0.74%
—
—
—
—
—
—
cases:4.34%
controls:1.40%
cases:7.18%
controls:5.22%
20
114
358
3656
6
28
373
3748
—
—
—
16
52
353
3671
25
180
323
3267
Localized oedema
R60.0 [45597193]
R60.0 [45597193]
7.0e-01
—
—
—
—
—
1.2e+00
cases:1.85%
controls:0.93%
—
—
—
—
—
—
—
—
—
—
cases:4.02%
controls:1.31%
7
35
371
3735
—
—
—
—
—
14
45
334
3402
pH of Specimen
17433-4 [3019225]
17433-4 [3019225]
—
—
—
—
—
—
1.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.02%
controls:1.31%
—
—
—
—
—
—
14
45
334
3402
Pain localized to upper abdomen
R10.1 [45568111]
R10.1 [45568111]
1.2e+00
1.6e+00
—
—
—
7.1e-01
7.8e-01
cases:3.44%
controls:1.11%
cases:2.11%
controls:0.45%
—
—
—
—
—
—
cases:1.63%
controls:0.81%
cases:5.17%
controls:2.44%
13
42
365
3728
8
17
371
3759
—
—
—
6
30
363
3693
18
84
330
3363
allopurinol; oral, parenteral
M04AA01 [21604131]
M04AA01 [21604131]
5.8e-01
8.1e-01
—
—
—
1.1e+00
9.0e-01
cases:3.44%
controls:1.96%
cases:2.64%
controls:1.19%
—
—
—
—
—
—
cases:3.52%
controls:1.15%
cases:4.60%
controls:1.91%
13
74
365
3696
10
45
369
3731
—
—
—
13
43
356
3680
16
66
332
3381
Rheumatology
66 [38004491]
66 [38004491]
5.8e-01
1.1e+00
-1.0e+50
—
—
9.9e-01
4.8e-01
cases:3.97%
controls:2.25%
cases:3.69%
controls:1.27%
cases:0.00%
controls:0.26%
—
—
—
—
cases:3.52%
controls:1.34%
cases:4.89%
controls:3.08%
15
85
363
3685
14
48
365
3728
0
10
379
3766
—
—
13
50
356
3673
17
106
331
3341
Primary arthrosis of other joints
M19.0 [45601353]
M19.0 [45601353]
1.1e+00
—
—
—
—
—
1.1e+00
cases:2.12%
controls:0.74%
—
—
—
—
—
—
—
—
—
—
cases:3.74%
controls:1.31%
8
28
370
3742
—
—
—
—
—
13
45
335
3402
Other primary gonarthrosis
M17.1 [45596493]
M17.1 [45596493]
4.6e-01
1.3e+00
—
—
—
1.1e+00
1.1e+00
cases:3.97%
controls:2.55%
cases:2.37%
controls:0.69%
—
—
—
—
—
—
cases:2.17%
controls:0.70%
cases:8.05%
controls:2.90%
15
96
363
3674
9
26
370
3750
—
—
—
8
26
361
3697
28
100
320
3347
omeprazole; oral, parenteral
A02BC01 [21600096]
A02BC01 [21600096]
5.7e-01
1.1e+00
1.4e+00
—
1.4e+00
2.1e-01
4.0e-01
cases:6.35%
controls:3.69%
cases:4.75%
controls:1.69%
cases:1.32%
controls:0.32%
—
—
cases:1.59%
controls:0.40%
cases:2.44%
controls:1.99%
cases:5.17%
controls:3.54%
24
139
354
3631
18
64
361
3712
5
12
374
3764
—
6
15
371
3758
9
74
360
3649
18
122
330
3325
Neck symptom/complaint
L01 [2002000626]
L01 [2002000626]
9.3e-01
—
-1.0e+50
—
—
—
1.1e+00
cases:2.12%
controls:0.85%
—
—
cases:0.00%
controls:0.16%
—
—
—
—
—
—
cases:5.17%
controls:1.86%
8
32
370
3738
—
0
6
379
3770
—
—
—
18
64
330
3383
Hypothyroidism, unspecified
E03.9 [45537945]
E03.9 [45537945]
1.0e+00
—
—
1.0e+50
—
1.3e+00
1.1e+00
cases:3.17%
controls:1.14%
—
—
—
—
cases:1.58%
controls:0.00%
—
—
cases:2.71%
controls:0.75%
cases:6.32%
controls:2.29%
12
43
366
3727
—
—
6
0
373
3776
—
10
28
359
3695
22
79
326
3368
zolpidem; oral
N05CF02 [21604655]
N05CF02 [21604655]
1.0e+00
8.0e-01
—
—
1.5e+00
8.4e-01
6.8e-01
cases:7.94%
controls:2.94%
cases:4.22%
controls:1.93%
—
—
—
—
cases:1.59%
controls:0.37%
cases:4.07%
controls:1.80%
cases:6.32%
controls:3.31%
30
111
348
3659
16
73
363
3703
—
—
6
14
371
3759
15
67
354
3656
22
114
326
3333
Asthma, unspecified
J45.9 [45562456]
J45.9 [45562456]
3.5e-01
7.0e-01
—
1.0e+50
—
1.0e+00
7.5e-01
cases:3.97%
controls:2.84%
cases:2.64%
controls:1.32%
—
—
cases:1.32%
controls:0.00%
—
—
cases:3.79%
controls:1.37%
cases:7.47%
controls:3.68%
15
107
363
3663
10
50
369
3726
—
5
0
374
3776
—
14
51
355
3672
26
127
322
3320
Telehealth
OMOP5556618 [722455]
OMOP5556618 [722455]
1.8e-01
2.4e-01
1.0e+00
—
7.9e-01
3.8e-01
3.2e-01
cases:20.37%
controls:17.64%
cases:12.14%
controls:9.80%
cases:5.01%
controls:1.85%
—
—
cases:4.51%
controls:2.09%
cases:14.63%
controls:10.53%
cases:31.61%
controls:25.12%
77
665
301
3105
46
370
333
3406
19
70
360
3706
—
17
79
360
3694
54
392
315
3331
110
866
238
2581
Endocrinology
46 [38004485]
46 [38004485]
4.0e-01
-3.2e-02
-1.0e+50
—
—
1.0e+00
3.5e-01
cases:3.70%
controls:2.52%
cases:1.85%
controls:1.91%
cases:0.00%
controls:0.34%
—
—
—
—
cases:4.61%
controls:1.72%
cases:5.17%
controls:3.68%
14
95
364
3675
7
72
372
3704
0
13
379
3763
—
—
17
64
352
3659
18
127
330
3320
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
N02AE01 [21604287]
1.1e+00
7.7e-01
—
—
—
5.3e-01
1.0e+00
cases:3.17%
controls:1.03%
cases:1.58%
controls:0.74%
—
—
—
—
—
—
cases:1.36%
controls:0.81%
cases:5.75%
controls:2.18%
12
39
366
3731
6
28
373
3748
—
—
—
5
30
364
3693
20
75
328
3372
Acute bronchitis, unspecified
J20.9 [45562445]
J20.9 [45562445]
1.0e+00
—
—
—
—
1.1e+00
3.6e-01
cases:5.03%
controls:1.91%
—
—
—
—
—
—
—
—
cases:1.90%
controls:0.67%
cases:4.02%
controls:2.84%
19
72
359
3698
—
—
—
—
7
25
362
3698
14
98
334
3349
Other gastroenteritis and colitis of infectious and unspecified origin
A09 [45605189]
A09 [45605189]
9.9e-01
7.0e-01
—
—
—
8.9e-01
6.9e-01
cases:4.23%
controls:1.62%
cases:1.32%
controls:0.66%
—
—
—
—
—
—
cases:1.63%
controls:0.67%
cases:4.02%
controls:2.06%
16
61
362
3709
5
25
374
3751
—
—
—
6
25
363
3698
14
71
334
3376
Medical Oncology
90 [38004507]
90 [38004507]
4.5e-02
7.9e-02
—
-1.0e+50
—
9.7e-01
4.8e-01
cases:2.91%
controls:2.79%
cases:2.37%
controls:2.20%
—
—
cases:0.00%
controls:0.13%
—
—
cases:5.15%
controls:2.01%
cases:5.46%
controls:3.45%
11
105
367
3665
9
83
370
3693
—
0
5
379
3771
—
19
75
350
3648
19
119
329
3328
Hand/finger symptom/complaint
L12 [2002000636]
L12 [2002000636]
—
—
—
—
—
1.3e+00
9.7e-01
—
—
—
—
—
—
—
—
—
—
cases:1.36%
controls:0.38%
cases:5.46%
controls:2.15%
—
—
—
—
—
5
14
364
3709
19
74
329
3373
General medical examination
Z00.0 [45585791]
Z00.0 [45585791]
7.5e-01
—
—
—
—
—
9.7e-01
cases:3.97%
controls:1.91%
—
—
—
—
—
—
—
—
—
—
cases:4.89%
controls:1.91%
15
72
363
3698
—
—
—
—
—
17
66
331
3381
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
N05BA01 [21604566]
9.3e-01
7.0e-01
—
—
—
9.2e-01
7.5e-01
cases:6.61%
controls:2.71%
cases:2.11%
controls:1.06%
—
—
—
—
—
—
cases:2.71%
controls:1.10%
cases:4.31%
controls:2.09%
25
102
353
3668
8
40
371
3736
—
—
—
10
41
359
3682
15
72
333
3375
tamsulosin; oral
G04CA02 [21602669]
G04CA02 [21602669]
6.4e-01
3.5e-01
—
—
—
4.9e-01
9.3e-01
cases:5.56%
controls:3.00%
cases:2.90%
controls:2.07%
—
—
—
—
—
—
cases:3.25%
controls:2.01%
cases:9.20%
controls:3.86%
21
113
357
3657
11
78
368
3698
—
—
—
12
75
357
3648
32
133
316
3314
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
30383-4 [3000850]
9.2e-01
1.1e+00
—
1.0e+50
—
9.0e-01
3.7e-01
cases:5.03%
controls:2.07%
cases:2.90%
controls:1.01%
—
—
cases:1.58%
controls:0.00%
—
—
cases:2.98%
controls:1.24%
cases:5.17%
controls:3.63%
19
78
359
3692
11
38
368
3738
—
6
0
373
3776
—
11
46
358
3677
18
125
330
3322
Hip symptom/complaint
L13 [2002000637]
L13 [2002000637]
5.7e-01
—
—
—
—
—
9.1e-01
cases:1.59%
controls:0.90%
—
—
—
—
—
—
—
—
—
—
cases:5.46%
controls:2.26%
6
34
372
3736
—
—
—
—
—
19
78
329
3369
Physical Medicine And Rehabilitation
25 [38004468]
25 [38004468]
2.9e-01
6.2e-01
—
—
—
9.1e-01
5.1e-01
cases:7.67%
controls:5.84%
cases:3.96%
controls:2.17%
—
—
—
—
—
—
cases:5.96%
controls:2.50%
cases:12.07%
controls:7.63%
29
220
349
3550
15
82
364
3694
—
—
—
22
93
347
3630
42
263
306
3184
fluconazole; oral, parenteral
J02AC01 [21603080]
J02AC01 [21603080]
5.5e-01
8.9e-01
—
—
1.6e+00
7.7e-01
9.0e-01
cases:10.58%
controls:6.37%
cases:3.96%
controls:1.67%
—
—
—
—
cases:1.33%
controls:0.27%
cases:3.79%
controls:1.80%
cases:10.92%
controls:4.73%
40
240
338
3530
15
63
364
3713
—
—
5
10
372
3763
14
67
355
3656
38
163
310
3284
escitalopram; oral
N06AB10 [21604718]
N06AB10 [21604718]
8.7e-01
8.2e-01
—
—
—
6.9e-01
3.8e-01
cases:7.14%
controls:3.13%
cases:4.22%
controls:1.91%
—
—
—
—
—
—
cases:3.52%
controls:1.80%
cases:4.60%
controls:3.19%
27
118
351
3652
16
72
363
3704
—
—
—
13
67
356
3656
16
110
332
3337
Functional capacity evaluation
443351003 [40481051]
443351003 [40481051]
9.0e-01
1.1e+00
—
—
—
1.3e+00
8.5e-01
cases:2.65%
controls:1.09%
cases:1.58%
controls:0.56%
—
—
—
—
—
—
cases:1.90%
controls:0.51%
cases:6.32%
controls:2.81%
10
41
368
3729
6
21
373
3755
—
—
—
7
19
362
3704
22
97
326
3350
tizanidine; oral
M03BX02 [21604116]
M03BX02 [21604116]
4.1e-01
8.3e-01
—
—
—
3.1e-01
4.8e-01
cases:16.40%
controls:11.51%
cases:7.12%
controls:3.23%
—
—
—
—
—
—
cases:5.15%
controls:3.81%
cases:16.38%
controls:10.82%
62
434
316
3336
27
122
352
3654
—
—
—
19
142
350
3581
57
373
291
3074
Urology
34 [38004474]
34 [38004474]
8.2e-01
3.4e-01
—
—
9.7e-01
5.0e-01
5.4e-01
cases:8.47%
controls:3.90%
cases:3.17%
controls:2.28%
—
—
—
—
cases:1.59%
controls:0.61%
cases:3.52%
controls:2.18%
cases:8.05%
controls:4.84%
32
147
346
3623
12
86
367
3690
—
—
6
23
371
3750
13
81
356
3642
28
167
320
3280
citalopram; oral, parenteral
N06AB04 [21604712]
N06AB04 [21604712]
8.1e-01
3.1e-01
—
—
—
1.0e-01
-9.8e-03
cases:6.61%
controls:3.05%
cases:2.37%
controls:1.75%
—
—
—
—
—
—
cases:1.90%
controls:1.72%
cases:3.16%
controls:3.19%
25
115
353
3655
9
66
370
3710
—
—
—
7
64
362
3659
11
110
337
3337
Rotator cuff syndrome
M75.1 [45596678]
M75.1 [45596678]
8.0e-01
1.1e+00
—
—
—
8.2e-01
7.3e-01
cases:6.08%
controls:2.84%
cases:2.90%
controls:1.03%
—
—
—
—
—
—
cases:2.71%
controls:1.21%
cases:7.18%
controls:3.60%
23
107
355
3663
11
39
368
3737
—
—
—
10
45
359
3678
25
124
323
3323
Chest pain, unspecified
R07.4 [45558450]
R07.4 [45558450]
3.0e-01
6.5e-01
—
—
—
—
7.9e-01
cases:4.50%
controls:3.37%
cases:2.11%
controls:1.11%
—
—
—
—
—
—
—
—
cases:8.62%
controls:4.12%
17
127
361
3643
8
42
371
3734
—
—
—
—
30
142
318
3305
Urgent procedure
ZXD05 [2001311386]
ZXD05 [2001311386]
7.8e-01
—
—
1.0e+50
—
9.2e-01
7.3e-01
cases:7.41%
controls:3.55%
—
—
—
—
cases:12.66%
controls:0.00%
—
—
cases:2.98%
controls:1.21%
cases:6.32%
controls:3.16%
28
134
350
3636
—
—
48
0
331
3776
—
11
45
358
3678
22
109
326
3338
mometasone; nasal
R01AD09 [21605051]
R01AD09 [21605051]
5.1e-01
7.6e-01
-1.0e+50
—
—
9.4e-02
5.6e-01
cases:12.96%
controls:8.20%
cases:6.86%
controls:3.34%
cases:0.00%
controls:0.42%
—
—
—
—
cases:3.79%
controls:3.46%
cases:13.79%
controls:8.38%
49
309
329
3461
26
126
353
3650
0
16
379
3760
—
—
14
129
355
3594
48
289
300
3158
Caries of dentine
K02.1 [45548134]
K02.1 [45548134]
2.5e-01
5.5e-01
—
—
1.0e+00
7.5e-01
4.5e-01
cases:11.90%
controls:9.55%
cases:8.18%
controls:4.87%
—
—
—
—
cases:1.33%
controls:0.48%
cases:9.76%
controls:4.86%
cases:21.84%
controls:15.14%
45
360
333
3410
31
184
348
3592
—
—
5
18
372
3755
36
181
333
3542
76
522
272
2925
mirtazapine; oral
N06AX11 [21604740]
N06AX11 [21604740]
4.6e-01
-9.1e-02
—
—
6.4e-01
4.1e-01
7.5e-01
cases:7.14%
controls:4.62%
cases:2.37%
controls:2.60%
—
—
—
—
cases:1.59%
controls:0.85%
cases:4.07%
controls:2.74%
cases:12.93%
controls:6.59%
27
174
351
3596
9
98
370
3678
—
—
6
32
371
3741
15
102
354
3621
45
227
303
3220
Two-surface restoration
SFA20 [2001310359]
SFA20 [2001310359]
4.6e-01
7.3e-01
—
—
—
5.4e-01
1.6e-01
cases:15.87%
controls:10.66%
cases:9.50%
controls:4.82%
—
—
—
—
—
—
cases:8.40%
controls:5.08%
cases:18.97%
controls:16.68%
60
402
318
3368
36
182
343
3594
—
—
—
31
189
338
3534
66
575
282
2872
orphenadrine (citrate); oral, parenteral
M03BC01 [21604112]
M03BC01 [21604112]
7.1e-01
7.9e-01
—
—
-1.0e+50
3.7e-01
4.2e-01
cases:10.85%
controls:5.62%
cases:4.22%
controls:1.96%
—
—
—
—
cases:0.00%
controls:0.13%
cases:2.44%
controls:1.69%
cases:9.48%
controls:6.44%
41
212
337
3558
16
74
363
3702
—
—
0
5
377
3768
9
63
360
3660
33
222
315
3225
orphenadrine (chloride); oral, parenteral
N04AB02 [21604458]
N04AB02 [21604458]
7.1e-01
7.9e-01
—
—
-1.0e+50
3.7e-01
4.2e-01
cases:10.85%
controls:5.62%
cases:4.22%
controls:1.96%
—
—
—
—
cases:0.00%
controls:0.13%
cases:2.44%
controls:1.69%
cases:9.48%
controls:6.44%
41
212
337
3558
16
74
363
3702
—
—
0
5
377
3768
9
63
360
3660
33
222
315
3225
Upper respiratory infection acute
R74 [2002000942]
R74 [2002000942]
2.9e-01
4.3e-01
—
—
—
2.6e-01
7.1e-01
cases:5.03%
controls:3.79%
cases:2.11%
controls:1.38%
—
—
—
—
—
—
cases:1.63%
controls:1.26%
cases:10.06%
controls:5.22%
19
143
359
3627
8
52
371
3724
—
—
—
6
47
363
3676
35
180
313
3267
prednisolone; oral, parenteral
H02AB06 [21602734]
H02AB06 [21602734]
2.9e-01
7.1e-01
1.3e+00
—
5.5e-01
4.9e-01
4.5e-01
cases:11.38%
controls:8.78%
cases:8.18%
controls:4.21%
cases:1.58%
controls:0.42%
—
—
cases:1.33%
controls:0.77%
cases:6.50%
controls:4.08%
cases:15.52%
controls:10.44%
43
331
335
3439
31
159
348
3617
6
16
373
3760
—
5
29
372
3744
24
152
345
3571
54
360
294
3087
Foot/toe symptom/complaint
L17 [2002000641]
L17 [2002000641]
-2.1e-01
4.7e-01
—
—
-1.0e+50
4.8e-01
7.0e-01
cases:2.12%
controls:2.60%
cases:2.11%
controls:1.32%
—
—
—
—
cases:0.00%
controls:0.16%
cases:1.90%
controls:1.18%
cases:9.20%
controls:4.79%
8
98
370
3672
8
50
371
3726
—
—
0
6
377
3767
7
44
362
3679
32
165
316
3282
prednisolone
A07EA01 [21600653]
A07EA01 [21600653]
3.1e-01
7.0e-01
1.3e+00
—
5.5e-01
4.9e-01
4.5e-01
cases:11.64%
controls:8.83%
cases:8.18%
controls:4.24%
cases:1.58%
controls:0.42%
—
—
cases:1.33%
controls:0.77%
cases:6.50%
controls:4.08%
cases:15.52%
controls:10.47%
44
333
334
3437
31
160
348
3616
6
16
373
3760
—
5
29
372
3744
24
152
345
3571
54
361
294
3086
diclofenac; oral, parenteral, rectal
M01AB05 [21603945]
M01AB05 [21603945]
4.2e-01
1.1e-01
—
—
—
3.2e-01
6.7e-01
cases:19.84%
controls:14.01%
cases:4.49%
controls:4.03%
—
—
—
—
—
—
cases:6.23%
controls:4.59%
cases:22.99%
controls:13.26%
75
528
303
3242
17
152
362
3624
—
—
—
23
171
346
3552
80
457
268
2990
cetirizine; oral
R06AE07 [21603497]
R06AE07 [21603497]
6.7e-01
3.5e-01
—
—
—
-8.9e-02
4.0e-01
cases:13.23%
controls:7.27%
cases:5.28%
controls:3.76%
—
—
—
—
—
—
cases:3.25%
controls:3.55%
cases:10.34%
controls:7.19%
50
274
328
3496
20
142
359
3634
—
—
—
12
132
357
3591
36
248
312
3199
Implementation of physical therapy rehabilitation plan
SPAT1223 [2001700324]
SPAT1223 [2001700324]
6.7e-01
7.2e-01
—
—
—
6.2e-01
6.4e-01
cases:4.76%
controls:2.49%
cases:2.64%
controls:1.30%
—
—
—
—
—
—
cases:2.71%
controls:1.48%
cases:10.34%
controls:5.72%
18
94
360
3676
10
49
369
3727
—
—
—
10
55
359
3668
36
197
312
3250
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
68438-1 [40771025]
3.9e-01
-5.9e-02
—
—
—
7.8e-01
6.2e-01
cases:5.56%
controls:3.85%
cases:2.37%
controls:2.52%
—
—
—
—
—
—
cases:5.15%
controls:2.42%
cases:16.09%
controls:9.37%
21
145
357
3625
9
95
370
3681
—
—
—
19
90
350
3633
56
323
292
3124
fluticasone furoate; nasal
R01AD12 [21605053]
R01AD12 [21605053]
2.2e-01
3.8e-01
-1.0e+50
—
—
-3.6e-01
6.0e-01
cases:9.26%
controls:7.59%
cases:4.75%
controls:3.31%
cases:0.00%
controls:0.37%
—
—
—
—
cases:2.71%
controls:3.84%
cases:13.51%
controls:7.92%
35
286
343
3484
18
125
361
3651
0
14
379
3762
—
—
10
143
359
3580
47
273
301
3174
fluticasone; nasal
R01AD08 [21605050]
R01AD08 [21605050]
2.2e-01
3.8e-01
-1.0e+50
—
—
-3.6e-01
6.0e-01
cases:9.26%
controls:7.59%
cases:4.75%
controls:3.31%
cases:0.00%
controls:0.37%
—
—
—
—
cases:2.71%
controls:3.84%
cases:13.51%
controls:7.92%
35
286
343
3484
18
125
361
3651
0
14
379
3762
—
—
10
143
359
3580
47
273
301
3174
azithromycin; oral, parenteral
J01FA10 [21602978]
J01FA10 [21602978]
5.8e-01
5.1e-01
-1.0e+50
—
—
2.0e-01
5.2e-01
cases:16.40%
controls:9.87%
cases:4.49%
controls:2.75%
cases:0.00%
controls:0.24%
—
—
—
—
cases:3.25%
controls:2.69%
cases:12.07%
controls:7.51%
62
372
316
3398
17
104
362
3672
0
9
379
3767
—
—
12
100
357
3623
42
259
306
3188
amoxicillin; oral, parenteral
J01CA04 [21602823]
J01CA04 [21602823]
2.6e-01
5.7e-01
7.3e-01
—
—
2.5e-01
2.4e-01
cases:30.16%
controls:24.91%
cases:12.14%
controls:7.23%
cases:1.58%
controls:0.77%
—
—
—
—
cases:8.94%
controls:7.12%
cases:25.57%
controls:21.26%
114
939
264
2831
46
273
333
3503
6
29
373
3747
—
—
33
265
336
3458
89
733
259
2714
estradiol; nasal, oral, parenteral, rectal, transdermal, vaginal
G03CA03 [21602517]
G03CA03 [21602517]
3.8e-01
5.5e-01
6.4e-01
—
6.6e-01
2.8e-01
1.8e-01
cases:21.16%
controls:15.52%
cases:17.15%
controls:10.67%
cases:4.22%
controls:2.28%
—
—
cases:3.98%
controls:2.09%
cases:13.82%
controls:10.80%
cases:19.83%
controls:17.15%
80
585
298
3185
65
403
314
3373
16
86
363
3690
—
15
79
362
3694
51
402
318
3321
69
591
279
2856
levothyroxine sodium; oral, parenteral
H03AA01 [21602754]
H03AA01 [21602754]
4.6e-01
4.3e-01
5.8e-01
—
4.3e-01
5.1e-01
5.4e-01
cases:11.64%
controls:7.69%
cases:11.87%
controls:8.08%
cases:4.49%
controls:2.57%
—
—
cases:3.18%
controls:2.09%
cases:13.01%
controls:8.27%
cases:16.09%
controls:10.01%
44
290
334
3480
45
305
334
3471
17
97
362
3679
—
12
79
365
3694
48
308
321
3415
56
345
292
3102
Obstetrics / Gynecology
16 [38004461]
16 [38004461]
5.2e-01
4.4e-01
6.7e-01
—
1.2e+00
5.2e-01
4.0e-01
cases:17.46%
controls:11.17%
cases:6.33%
controls:4.18%
cases:1.85%
controls:0.95%
—
—
cases:2.39%
controls:0.72%
cases:7.05%
controls:4.30%
cases:14.37%
controls:10.12%
66
421
312
3349
24
158
355
3618
7
36
372
3740
—
9
27
368
3746
26
160
343
3563
50
349
298
3098
Lipid disorder
T93 [2002001134]
T93 [2002001134]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.24%
—
—
—
—
—
—
—
—
—
—
—
0
9
379
3767
—
—
—
—
—
Methemoglobin/Hemoglobin.total in Venous blood
2617-9 [3024889]
2617-9 [3024889]
—
-1.0e+50
—
—
—
2.1e+00
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
cases:1.36%
controls:0.16%
—
—
—
0
10
379
3766
—
—
—
5
6
364
3717
—
Hyperlipidaemia, unspecified
E78.5 [45537986]
E78.5 [45537986]
-2.3e-02
—
—
—
—
—
4.9e-01
cases:1.32%
controls:1.35%
—
—
—
—
—
—
—
—
—
—
cases:2.59%
controls:1.60%
5
51
373
3719
—
—
—
—
—
9
55
339
3392
palonosetron, combinations
A04AA55 [45893275]
A04AA55 [45893275]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
0
8
348
3439
Transurethral resection of bladder
KCD02 [2001305938]
KCD02 [2001305938]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.17%
0
6
378
3764
—
—
—
—
—
0
6
348
3441
colestipol; oral
C10AC02 [21601877]
C10AC02 [21601877]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
378
3765
—
—
—
—
—
—
mefenamic acid; oral
M01AG01 [21603987]
M01AG01 [21603987]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
378
3764
—
—
—
—
—
—
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
AA1BG [2001300112]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.16%
—
—
—
—
—
—
—
0
6
369
3717
—
lorazepam; oral, parenteral, sublingual
N05BA06 [21604571]
N05BA06 [21604571]
1.5e+00
—
—
—
-1.0e+50
—
—
cases:2.12%
controls:0.50%
—
—
—
—
—
—
cases:0.00%
controls:0.16%
—
—
—
—
8
19
370
3751
—
—
—
0
6
377
3767
—
—
Seborrhoeic dermatitis
L21 [45596367]
L21 [45596367]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
378
3764
—
—
—
—
—
—
Lutropin [Units/volume] in Serum or Plasma
10501-5 [3009214]
10501-5 [3009214]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
—
0
7
379
3769
—
—
—
—
—
Eye pain
F01 [2002000399]
F01 [2002000399]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
0
8
348
3439
Diffusion capacity of lung
54715006 [4182985]
54715006 [4182985]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
378
3763
—
—
—
—
—
—
lithium; oral
N05AN01 [21604556]
N05AN01 [21604556]
—
-1.0e+50
—
—
-1.0e+50
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:0.19%
—
—
—
—
cases:0.00%
controls:0.13%
cases:0.00%
controls:0.19%
cases:0.00%
controls:0.20%
—
0
7
379
3769
—
—
0
5
377
3768
0
7
369
3716
0
7
348
3440
Moderate panic disorder
F41.00 [2000501994]
F41.00 [2000501994]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
378
3765
—
—
—
—
—
—
Chondromalacia patellae
M22.4 [45538712]
M22.4 [45538712]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.17%
0
6
378
3764
—
—
—
—
—
0
6
348
3441
Cholesterol [Moles/volume] in Serum or Plasma
14647-2 [3019900]
14647-2 [3019900]
-7.2e-02
2.3e-01
6.5e-01
—
5.4e-01
-6.1e-02
4.3e-02
cases:13.49%
controls:14.35%
cases:11.35%
controls:9.27%
cases:2.11%
controls:1.11%
—
—
cases:2.12%
controls:1.25%
cases:10.84%
controls:11.44%
cases:36.49%
controls:35.51%
51
541
327
3229
43
350
336
3426
8
42
371
3734
—
8
47
369
3726
40
426
329
3297
127
1224
221
2223
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
14338-8 [3013742]
—
9.2e-01
—
—
—
1.0e+00
3.9e-01
—
—
cases:1.58%
controls:0.64%
—
—
—
—
—
—
cases:1.36%
controls:0.48%
cases:2.30%
controls:1.57%
—
6
24
373
3752
—
—
—
5
18
364
3705
8
54
340
3393
Senile nuclear cataract
H25.1 [45581628]
H25.1 [45581628]
1.4e-01
—
—
—
—
—
3.9e-02
cases:2.91%
controls:2.55%
—
—
—
—
—
—
—
—
—
—
cases:3.74%
controls:3.60%
11
96
367
3674
—
—
—
—
—
13
124
335
3323
betamethasone
S02BA07 [21605169]
S02BA07 [21605169]
1.0e-01
-4.3e-01
-1.0e+50
—
-1.0e+50
—
4.2e-01
cases:5.82%
controls:5.28%
cases:1.58%
controls:2.41%
cases:0.00%
controls:0.26%
—
—
cases:0.00%
controls:0.27%
—
—
cases:9.77%
controls:6.61%
22
199
356
3571
6
91
373
3685
0
10
379
3766
—
0
10
377
3763
—
34
228
314
3219
General and Unspecified, Result test/procedure
A60 [2002000194]
A60 [2002000194]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.19%
—
—
—
—
—
—
—
0
7
369
3716
—
Estradiol (E2) [Moles/volume] in Serum or Plasma
14715-7 [3026725]
14715-7 [3026725]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.20%
—
—
—
—
—
—
0
7
348
3440
Impingement syndrome of shoulder
M75.4 [45553266]
M75.4 [45553266]
—
—
—
—
—
—
6.9e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.44%
controls:0.73%
—
—
—
—
—
—
5
25
343
3422
dexamethasone
S01BA01 [21603618]
S01BA01 [21603618]
4.8e-01
—
—
—
-1.0e+50
4.6e-01
2.2e-01
cases:3.17%
controls:1.99%
—
—
—
—
—
—
cases:0.00%
controls:0.19%
cases:1.36%
controls:0.86%
cases:3.45%
controls:2.79%
12
75
366
3695
—
—
—
0
7
377
3766
5
32
364
3691
12
96
336
3351
Family history of malignant neoplasm of breast
Z80.3 [45556856]
Z80.3 [45556856]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
0
5
379
3771
—
—
—
—
0
5
348
3442
Excision of lesion of eyelid
CBB30 [2001300933]
CBB30 [2001300933]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
378
3763
—
—
—
—
—
—
fentanyl; nasal, sublingual, transdermal
N02AB03 [21604272]
N02AB03 [21604272]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.72%
controls:0.41%
—
—
—
—
—
—
6
14
342
3433
Zoster [herpes zoster]
B02 [45552205]
B02 [45552205]
-1.0e+50
—
—
—
—
—
1.0e+00
cases:0.00%
controls:0.27%
—
—
—
—
—
—
—
—
—
—
cases:1.44%
controls:0.52%
0
10
378
3760
—
—
—
—
—
5
18
343
3429
Gonarthrosis [arthrosis of knee]
M17 [45601350]
M17 [45601350]
—
—
—
—
—
—
3.9e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.59%
controls:1.77%
—
—
—
—
—
—
9
61
339
3386
Acute bronchitis
J20 [45581849]
J20 [45581849]
4.1e-01
—
—
—
—
-1.0e+50
1.0e+00
cases:1.59%
controls:1.06%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.35%
cases:3.16%
controls:1.13%
6
40
372
3730
—
—
—
—
0
13
369
3710
11
39
337
3408
Alzheimer disease, unspecified
G30.9 [45591165]
G30.9 [45591165]
-1.0e+50
—
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.19%
cases:0.00%
controls:0.35%
0
5
378
3765
—
—
—
—
0
7
369
3716
0
12
348
3435
Clarification/discussion RFE/demand
-48 [2002000119]
-48 [2002000119]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
378
3763
—
—
—
—
—
—
lidocaine
C05AD01 [21601618]
C05AD01 [21601618]
—
-1.0e+50
—
—
—
—
1.2e+00
—
—
cases:0.00%
controls:0.21%
—
—
—
—
—
—
—
—
cases:1.72%
controls:0.55%
—
0
8
379
3768
—
—
—
—
6
19
342
3428
aciclovir
S01AD03 [21603588]
S01AD03 [21603588]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.29%
—
—
—
—
—
—
0
10
348
3437
Palpitations/awareness of heart
K04 [2002000547]
K04 [2002000547]
—
—
—
—
—
—
7.3e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.44%
controls:0.70%
—
—
—
—
—
—
5
24
343
3423
Female infertility, unspecified
N97.9 [45582432]
N97.9 [45582432]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.29%
—
—
—
—
—
—
—
—
—
—
—
—
0
11
378
3759
—
—
—
—
—
—
Acute conjunctivitis, unspecified
H10.3 [45566958]
H10.3 [45566958]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.29%
—
—
—
—
—
—
—
—
—
—
—
—
0
11
378
3759
—
—
—
—
—
—
Person encountering health services in unspecified circumstances
Z76.9 [45609967]
Z76.9 [45609967]
—
—
—
—
—
—
2.2e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.44%
controls:1.16%
—
—
—
—
—
—
5
40
343
3407
Colpoperineoplasty and vaginal hysterectomy
LEF13 [2001306713]
LEF13 [2001306713]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
378
3764
—
—
—
—
—
—
norethisterone; oral
G03DC02 [21602553]
G03DC02 [21602553]
6.5e-01
—
—
—
—
—
3.3e-01
cases:2.12%
controls:1.11%
—
—
—
—
—
—
—
—
—
—
cases:1.72%
controls:1.25%
8
42
370
3728
—
—
—
—
—
6
43
342
3404
Acute pericoronitis
K05.22 [2000502725]
K05.22 [2000502725]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.20%
0
5
378
3765
—
—
—
—
—
0
7
348
3440
Erythrocytes [#/area] in Urine sediment by Automated count
46419-8 [3048402]
46419-8 [3048402]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
0
5
348
3442
Thyroglobulin Ab [Units/volume] in Serum or Plasma
8098-6 [3025547]
8098-6 [3025547]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
0
8
348
3439
Divergent concomitant strabismus
H50.1 [45591385]
H50.1 [45591385]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
378
3765
—
—
—
—
—
—
Enthesopathy, unspecified
M77.9 [45591933]
M77.9 [45591933]
-1.0e+50
—
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.16%
cases:0.00%
controls:0.29%
0
5
378
3765
—
—
—
—
0
6
369
3717
0
10
348
3437
Open wound of other parts of foot
S91.3 [45599027]
S91.3 [45599027]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.27%
—
—
—
—
—
—
—
—
—
—
—
—
0
10
378
3760
—
—
—
—
—
—
Urine culture
117010004 [4024509]
117010004 [4024509]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.19%
—
—
—
—
—
—
—
0
7
369
3716
—
Eye pressure measurement
XCH00 [2001301234]
XCH00 [2001301234]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.24%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.16%
—
—
0
9
378
3761
—
—
—
—
0
6
369
3717
—
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
283
1932
2.38
15.83
9.0
6.7
12.98
12.62
umol/l
0.09
270
1840
358
2744
2.91
15.30
11.6
8.0
87.36
84.32
u/l
0.34
348
2595
194
1150
2.26
14.95
3.3
2.5
81.61
65.50
u/l
0.21
189
1071
120
587
2.45
14.35
3.6
2.6
167.80
100.75
ug/g
0.50
98
473
242
1589
2.21
14.26
8.8
5.3
36.04
36.08
g/l
0.04
229
1506
64
263
2.69
10.79
1.9
1.6
—
—
—
0
0
145
911
1.90
8.44
4.0
2.4
—
—
—
0
0
35
119
3.11
8.29
1.9
1.3
—
—
—
0
0
113
659
1.97
8.17
4.5
3.1
3.51
2.22
e6/l
0.44
63
327
302
2395
1.90
8.15
7.0
4.5
28.13
807.83
e6/l
—
8
42
232
1698
1.80
8.14
4.0
2.9
—
—
estimate
—
0
0
253
1909
1.80
7.93
14.8
8.0
1.21
1.22
mmol/l
0.23
224
1668
70
347
2.22
7.76
17.7
10.5
1.25
1.32
mmol/l
0.31
70
340
134
844
1.86
7.61
4.1
2.6
6.76
5.22
e6/l
0.45
125
762
229
1705
1.74
7.27
4.2
2.7
74.68
75.31
nmol/l
0.13
205
1544
162
1095
1.77
7.22
5.3
3.3
0.30
0.37
e6/l
0.27
132
784
83
455
2.02
7.07
8.7
2.8
4.59
7.40
umol/l
2.10
76
394
114
697
1.87
7.04
4.6
3.0
1.56
0.81
e6/l
0.66
66
361
281
2229
1.77
7.01
10.5
5.6
6.45
6.55
mmol/l
0.41
270
2109
283
2251
1.77
6.98
12.7
10.3
4.50
4.01
e9/l
2.00
240
1954
181
1273
1.73
6.95
5.9
3.3
30.95
31.45
u/l
0.09
169
1204
66
335
2.15
6.88
16.1
5.8
24.36
23.86
mmol/l
0.85
66
335
231
1745
1.71
6.78
17.7
7.9
1.21
1.22
mmol/l
0.54
212
1625
72
382
2.06
6.68
3.9
2.4
34.37
31.46
u/l
0.32
63
315
326
2726
1.83
6.52
5.4
4.5
11.89
11.03
mm/h
0.49
315
2549
402
3653
2.78
6.00
31.7
17.8
139.46
139.65
mmol/l
0.88
392
3586
100
617
1.81
5.90
8.3
4.3
0.82
0.82
mmol/l
0.17
95
588
402
3658
2.76
5.89
32.1
17.9
3.98
3.97
mmol/l
0.25
393
3581
58
300
2.08
5.74
6.0
4.5
66.81
73.01
ng/l
0.35
51
269
27
99
2.84
5.64
1.6
1.5
—
—
—
0
0
249
1975
1.63
5.61
4.3
3.7
0.00
0.00
estimate
-0.00
54
390
204
1542
1.62
5.60
2.6
2.1
94.61
95.92
pmol/l
0.15
109
788
296
2463
1.66
5.40
6.4
3.4
47.19
45.16
u/l
0.12
283
2331
249
1993
1.60
5.26
4.4
3.7
0.00
4.11
estimate
0.50
53
395
77
455
1.85
5.18
17.1
5.4
1.60
1.46
mmol/l
0.15
68
385
250
2013
1.59
5.07
4.4
3.8
17.86
0.01
estimate
0.49
56
369
66
376
1.89
4.97
5.4
2.7
0.23
0.22
g/l
0.55
60
353
210
1635
1.56
4.86
16.8
11.6
1.26
1.21
inr
0.68
173
1327
83
513
1.77
4.80
19.0
8.2
105.39
104.22
mmol/l
1.55
83
513
77
467
1.79
4.75
17.6
5.3
5.84
5.76
kpa
0.34
77
455
108
721
1.67
4.73
4.5
3.8
408.11
358.15
ng/l
0.09
76
553
27
109
2.58
4.73
1.7
1.4
344.31
296.76
ug/g
0.49
19
66
170
1270
1.56
4.67
3.3
3.2
2.36
2.36
mmol/l
0.16
162
1147
138
988
1.59
4.53
4.4
2.4
2.81
2.84
mg/l
0.06
123
857
47
246
2.02
4.51
3.3
3.1
278.36
170.65
ng/l
0.80
42
222
226
1813
1.53
4.41
4.5
3.0
101.97
109.19
ug/l
0.26
206
1690
56
316
1.89
4.34
13.0
5.4
2.06
1.48
mmol/l
0.83
45
242
408
3811
2.67
4.32
29.4
19.1
75.24
73.86
umol/l
0.23
403
3768
92
610
1.65
4.09
2.1
2.0
—
—
—
0
0
25
105
2.47
4.06
2.8
3.0
0.94
5.57
index
0.76
18
58
394
3644
2.08
3.99
27.2
15.1
29.47
23.10
mg/l
3.08
358
2915
68
421
1.73
3.89
17.7
5.0
5.32
4.68
kpa
1.47
68
411
364
3294
1.72
3.84
22.8
14.5
85.12
84.06
ml/min/173m2
0.40
341
3006
29
134
2.25
3.83
1.5
1.2
—
—
—
0
0
118
843
1.55
3.83
2.9
2.1
0.91
1.21
mg/l
1.05
92
649
61
369
1.76
3.78
4.2
4.2
2.98
20.10
ug/l
0.85
43
303
68
425
1.71
3.76
3.4
5.0
222.29
263.51
u/l
1.14
63
405
325
2869
1.56
3.71
5.1
4.2
14.84
14.74
pmol/l
0.31
308
2624
65
403
1.72
3.70
9.4
11.0
0.35
0.82
mmol/l
0.45
58
350
403
3775
2.25
3.68
18.2
11.8
28.98
26.42
u/l
0.92
392
3671
86
576
1.62
3.66
3.2
2.5
2.48
2.35
g/l
1.18
78
529
11
27
4.15
3.41
2.1
2.8
0.36
0.93
index
2.10
11
27
7
10
7.10
3.37
5.3
3.0
0.62
0.60
mmol/l
—
7
10
26
123
2.19
3.27
2.1
1.8
—
—
—
0
0
98
705
1.51
3.02
1.8
1.7
396.12
19664305.04
pmol/l
0.50
86
595
89
629
1.52
2.98
3.3
2.4
11.48
13.33
umol/l
1.56
82
584
11
32
3.50
2.92
5.9
3.2
101.64
103.53
%
0.06
11
32
39
224
1.82
2.89
17.9
4.5
0.62
0.62
%
0.02
39
224
285
2506
1.41
2.84
3.3
3.3
—
—
—
0
0
24
117
2.11
2.83
1.5
1.1
—
—
—
0
0
38
219
1.81
2.79
1.8
1.6
—
—
—
0
0
23
111
2.13
2.78
2.1
1.7
—
—
—
0
0
24
118
2.10
2.77
1.5
1.1
—
—
—
0
0
20
93
2.21
2.65
1.4
1.5
—
—
—
0
0
76
536
1.51
2.56
3.4
2.5
18.40
22.62
%
1.85
68
501
95
705
1.45
2.48
2.8
2.7
2.44
2.45
mmol/l
0.25
85
630
135
1067
1.39
2.48
3.3
3.6
1340.38
1062.26
ng/l
0.24
112
912
6
12
5.05
2.41
2.2
2.0
130.05
56.69
ug/l
—
6
12
413
3974
2.29
2.35
38.7
23.1
261.72
252.68
e9/l
1.85
408
3892
132
1048
1.38
2.34
2.0
1.7
22.87
20.82
nmol/l
0.64
113
882
17
78
2.23
2.34
1.6
1.3
14805.00
21411.26
e6/l
0.29
12
57
413
3976
2.27
2.31
38.5
23.0
4.52
4.52
e12/l
0.09
407
3883
362
3369
1.50
2.31
6.4
5.2
1.80
1.89
mu/l
0.94
345
3113
6
13
4.66
2.28
1.2
1.3
—
—
—
0
0
176
1470
1.34
2.23
4.1
3.6
11.63
0.01
estimate
0.49
43
326
23
122
1.94
2.20
1.6
1.8
—
—
—
0
0
28
160
1.80
2.15
1.5
2.2
1.68
1.44
g/l
0.48
20
144
66
469
1.48
2.15
2.0
1.9
—
—
—
0
0
22
116
1.95
2.15
1.5
1.3
—
—
—
0
0
132
1062
1.35
2.13
4.7
3.9
0.00
0.00
estimate
0.50
48
367
84
627
1.42
2.12
1.4
1.3
9.71
9.36
u/ml
0.02
29
225
26
148
1.81
2.03
14.0
4.5
3.02
3.30
g/l
0.80
26
143
11
44
2.54
2.02
1.5
1.4
—
—
—
0
0
11
44
2.54
2.02
1.5
1.4
—
—
—
0
0
41
267
1.59
1.98
2.2
2.2
7.21
6.37
ug/l
0.16
34
237
18
91
2.02
1.98
1.7
2.3
127.00
129.56
g/l
0.17
13
71
31
188
1.70
1.97
1.3
1.4
—
—
—
0
0
15
71
2.15
1.94
1.9
1.5
—
—
—
0
0
11
45
2.48
1.94
1.5
1.4
—
—
—
0
0
9
33
2.76
1.94
2.6
2.4
—
—
—
0
0
112
892
1.35
1.91
3.3
3.1
333.04
339.46
umol/l
0.26
96
786
21
114
1.89
1.91
1.5
1.7
—
—
—
0
0
32
199
1.66
1.86
1.8
1.8
21.79
20.31
iu/l
0.09
27
159
26
153
1.74
1.84
1.5
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
18
94
1.96
1.83
6.1
5.3
0.28
0.34
iu/ml
0.49
12
53
11
47
2.38
1.79
1.9
1.4
—
—
—
0
0
11
47
2.38
1.79
2.0
3.2
—
—
—
0
0
11
47
2.38
1.79
1.9
1.4
—
—
—
0
0
11
47
2.38
1.79
1.9
1.4
—
—
—
0
0
37
242
1.58
1.78
20.7
4.7
129.76
130.44
g/l
0.07
37
236
5
13
3.88
1.72
1.2
3.2
176.20
196.85
u/l
—
5
13
11
48
2.33
1.72
1.1
1.4
—
—
—
0
0
132
1095
1.30
1.68
1.4
1.5
2.73
1.84
u/ml
0.28
36
267
60
441
1.42
1.66
2.1
2.0
—
—
—
0
0
22
128
1.76
1.63
1.8
2.1
196.55
299.86
ug/l
0.62
22
121
152
1288
1.28
1.63
3.8
3.6
7.29
7.87
mmol/l
0.81
128
1096
18
99
1.85
1.60
2.1
1.6
—
—
—
0
0
108
878
1.31
1.59
4.8
3.7
1.02
1.02
kg/l
1.04
75
577
176
1523
1.27
1.58
2.3
2.0
1.35
1.34
mmol/l
0.01
149
1300
21
123
1.74
1.54
1.0
1.4
341.33
246.83
miu/ml
—
6
58
57
422
1.40
1.53
1.9
2.1
345.47
374.49
nmol/l
0.54
51
397
5
15
3.36
1.52
1.4
1.6
—
—
—
0
0
11
51
2.19
1.52
2.7
1.3
0.55
37.46
nmol/l
0.49
11
46
342
3216
1.32
1.50
4.7
4.2
1.32
1.27
mmol/l
0.73
321
2971
7
28
2.52
1.45
1.0
1.1
—
—
—
0
0
5
16
3.15
1.44
1.4
1.6
—
—
—
0
0
6
22
2.75
1.44
1.7
1.4
—
—
—
0
0
6
22
2.75
1.44
1.7
1.4
—
—
—
0
0
87
696
1.31
1.43
1.4
1.3
43.45
26.89
iu/ml
0.40
23
203
10
46
2.20
1.41
2.8
1.2
0.23
0.17
nmol/l
—
10
31
32
215
1.53
1.40
1.5
1.3
—
—
—
0
0
12
60
2.03
1.39
1.5
1.7
—
—
—
0
0
24
152
1.61
1.35
3.7
2.3
24540.73
5351.75
u/l
0.39
11
53
5
18
2.80
1.29
1.8
1.3
—
—
—
0
0
5
18
2.80
1.29
1.8
1.3
—
—
—
0
0
5
18
2.80
1.29
1.4
1.6
—
—
—
0
0
105
876
1.26
1.25
1.9
1.7
—
—
—
0
0
43
315
1.41
1.25
4.2
2.4
0.42
0.21
e6/l
0.39
43
296
6
25
2.42
1.24
3.0
1.6
89.67
73.64
umol/l
—
6
25
70
556
1.31
1.22
2.0
1.7
1157.63
1204.36
nmol/l
0.15
49
414
91
749
1.27
1.21
4.0
4.3
21.42
22.55
%
0.29
42
330
37
268
1.42
1.15
1.0
1.0
—
—
—
0
0
17
103
1.68
1.14
2.0
1.5
257.88
216.43
u/ml
—
8
51
14
80
1.78
1.14
1.2
1.2
—
—
—
0
0
14
80
1.78
1.14
1.2
1.2
—
—
—
0
0
18
111
1.65
1.14
1.9
1.5
—
—
—
0
0
38
279
1.40
1.10
14.3
3.5
1.23
1.23
mmol/l
0.25
32
238
14
81
1.75
1.10
1.6
1.6
—
—
—
0
0
16
97
1.67
1.08
1.4
1.8
4.30
4.32
iu/l
—
6
38
17
105
1.64
1.07
1.5
1.5
—
—
—
0
0
14
82
1.73
1.06
1.6
1.5
—
—
—
0
0
22
146
1.53
1.05
1.8
1.6
16.81
10.54
u/ml
—
7
30
132
1151
1.21
1.04
4.2
4.1
3.33
8.62
mg/mmol
2.38
79
715
14
83
1.71
1.02
1.6
1.2
—
—
—
0
0
10
53
1.91
1.02
1.5
1.4
—
—
—
0
0
359
3448
1.26
0.97
6.3
5.7
2.64
2.70
mmol/l
0.74
342
3217
7
36
1.96
0.97
6.9
3.3
2.03
3.58
nmol/l
—
7
36
9
50
1.82
0.97
1.8
1.3
450.33
577.70
pmol/l
—
9
43
124
1084
1.20
0.95
3.7
3.2
6.40
0.00
estimate
0.55
43
316
341
3261
1.23
0.94
7.3
6.2
38.73
38.96
mmol/mol
0.20
328
3067
6
27
2.24
0.94
1.0
1.1
—
—
—
0
0
65
532
1.26
0.92
1.4
1.5
—
—
—
0
0
355
3411
1.24
0.92
5.7
5.0
4.48
4.61
mmol/l
1.56
340
3184
109
949
1.20
0.87
5.3
5.2
1.81
2.32
ug/l
0.57
98
851
58
472
1.26
0.87
1.8
1.8
1.39
1.47
%
0.47
50
420
68
564
1.24
0.87
2.8
3.0
0.56
0.82
ug/l
2.70
45
353
8
45
1.79
0.84
1.3
1.1
—
—
—
0
0
35
268
1.33
0.82
4.7
2.7
70.18
66.53
ml/min/173m2
0.23
11
119
352
3390
1.22
0.82
5.4
4.9
1.38
1.46
mmol/l
4.18
336
3153
6
33
1.83
0.79
1.0
1.0
—
—
—
0
0
5
24
2.10
0.74
1.6
1.5
—
—
—
0
0
7
38
1.86
0.74
1.4
1.3
90.71
110.11
pmol/l
—
7
38
7
39
1.81
0.73
1.3
1.2
—
—
—
0
0
5
26
1.93
0.71
1.0
1.0
—
—
—
0
0
7
41
1.72
0.70
1.3
1.1
—
—
—
0
0
7
41
1.72
0.70
1.3
1.1
—
—
—
0
0
10
61
1.65
0.69
1.4
1.6
—
—
—
0
0
15
102
1.49
0.68
1.3
2.0
—
—
—
0
0
8
49
1.64
0.62
2.3
1.2
—
—
—
0
0
5
30
1.67
0.61
1.0
1.4
4.32
4.04
umol/l
—
5
25
8
50
1.61
0.61
1.3
1.2
—
—
—
0
0
8
54
1.49
0.57
1.4
1.6
—
—
—
0
0
10
148
0.67
0.56
1.5
1.7
—
—
—
0
0
6
37
1.63
0.55
1.3
1.1
—
—
—
0
0
11
74
1.50
0.54
2.2
2.4
232.50
103.36
ug/min
—
6
41
145
1340
1.12
0.52
4.9
3.7
25.68
32.73
ng/l
0.62
101
930
6
40
1.51
0.52
1.5
1.4
—
—
—
0
0
342
3324
1.15
0.51
5.9
4.9
5.87
5.90
mmol/l
0.22
320
3063
11
76
1.46
0.48
1.4
1.9
—
—
—
0
0
7
46
1.53
0.48
1.0
2.0
9.57
10.65
mmol/l
—
7
46
7
48
1.47
0.47
1.9
1.5
—
—
—
0
0
7
50
1.41
0.45
1.1
1.1
—
—
—
0
0
39
333
1.19
0.42
2.0
2.5
11.24
13.23
nmol/l
0.74
34
303
5
33
1.52
0.41
1.0
1.0
7.18
6.61
kpa
—
5
28
5
33
1.52
0.41
1.0
1.0
2.76
3.76
kpa
—
5
28
5
33
1.52
0.41
2.0
2.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
15
114
1.33
0.41
2.1
2.9
—
—
—
0
0
17
132
1.30
0.41
1.5
1.1
0.92
0.92
g/l
0.00
17
132
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
10
71
1.42
0.39
1.3
1.1
—
—
—
0
0
9
67
1.35
0.38
1.1
1.5
86.41
48.34
ug/l
—
9
67
6
41
1.47
0.36
1.3
1.1
—
—
—
0
0
6
46
1.31
0.33
1.0
1.2
—
68.00
—
0
5
23
192
1.21
0.33
2.3
3.0
40.78
111.73
u/ml
0.55
23
185
46
410
1.14
0.31
5.2
4.8
32.53
31.89
%
0.15
34
259
7
53
1.33
0.31
1.0
1.1
—
—
—
0
0
7
53
1.33
0.31
1.0
1.1
—
—
—
0
0
21
176
1.20
0.29
1.4
2.2
1.45
5.00
iu/ml
—
6
43
7
57
1.23
0.29
2.0
1.9
—
—
—
0
0
8
62
1.30
0.28
1.1
1.5
—
156.67
—
0
6
8
63
1.27
0.28
1.0
1.1
—
—
—
0
0
33
291
1.15
0.27
2.0
2.0
—
—
—
0
0
40
359
1.13
0.25
5.7
6.7
—
—
—
0
0
9
74
1.22
0.25
2.3
1.4
—
—
—
0
0
5
39
1.29
0.23
1.4
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
6
48
1.25
0.20
1.0
1.1
—
—
—
0
0
6
51
1.18
0.19
1.8
1.3
—
—
—
0
0
6
52
1.16
0.19
1.0
1.0
—
—
—
0
0
12
100
1.21
0.18
1.3
1.2
—
1.00
—
0
7
38
350
1.09
0.17
5.3
3.3
—
—
—
0
0
12
101
1.19
0.16
1.2
1.2
—
41.19
—
0
15
11
92
1.20
0.16
1.4
1.3
—
—
—
0
0
25
276
0.90
0.16
1.2
1.2
47.68
147.89
u/ml
—
9
108
8
73
1.10
0.16
14.5
2.9
11.46
8.75
pmol/l
—
8
73
7
87
0.80
0.14
1.6
1.7
—
—
—
0
0
16
141
1.14
0.14
1.2
1.3
—
—
—
0
0
5
46
1.09
0.09
1.0
2.1
—
—
—
0
0
26
244
1.07
0.08
1.8
1.9
—
—
—
0
0
6
75
0.80
0.07
2.8
1.8
—
—
—
0
0
9
88
1.02
0.07
2.3
1.3
—
—
—
0
0
53
512
1.04
0.07
2.2
2.2
—
—
—
0
0
13
142
0.91
0.06
1.2
1.1
6.42
5.23
—
5
15
27
282
0.95
0.04
1.9
1.7
3.65
3.52
mmol/l
0.24
20
205
48
468
1.03
0.03
2.2
2.1
—
—
—
0
0
12
128
0.94
0.02
1.0
1.1
1.37
1.57
g/l
1.77
12
128
37
376
0.98
0.00
2.1
1.9
3.62
3.55
ratio
0.14
32
296
11
105
1.05
0.00
1.5
1.2
—
—
—
0
0
29
288
1.01
0.00
1.4
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
10.1
—
10.11
—
0
7
0
7
0.00
-0.00
0.0
3.6
—
35.14
—
0
7
8
80
1.00
-0.00
2.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
79.14
—
0
7
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
79
1.01
-0.00
1.6
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.7
—
25.98
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
13
130
1.00
-0.00
1.5
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: Q17_OTHER_CONGEN_MALFO_INTESTINE_WIDE – Other congenital malformations of intestine, including avohilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).